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Abstract 
There are a large variety of factors that affect performance in physical tasks. One factor is the 
muscle myosin heavy chain (MHC) composition of the muscle involved in the task. Differences 
in MHC can affect not just exercise performance, but can be related to general health. Purpose: 
The purpose of this study was to examine the relationship between exercise performance and 
MHC composition. Methods: Forty two (n=42) males of a variety of training backgrounds 
(aerobically trained, resistance trained, recreationally trained, and sedentary) took part in this 
study (Age = 22.4±3.5 years, Height 1.78±.07m, Weight 78.7±13.3 kg). Subjects were 
familiarized with vertical jumps, as well as maximal and fatiguing leg extensions during their 
first visit. A DEXA scan was performed on each subject along with thigh girth and skinfold 
caliper measurements. The following visit, subjects performed 2 reps of the following jump 
variations: counter movement jump, with and without arm swing, and depth jumps. Each jump 
was recorded utilizing a 2 dimensional force plate. Subjects then were tested for leg extension 
one repetition maximum (1RM). During the final testing session, subjects performed maximal 
velocity leg extensions at 30, 40, 50, 60, 70, 80, and 90% of their 1RM. Subjects then performed 
15 maximal velocity repetitions at 70% of their 1RM on a cadence. Each rep of leg extension 
performance was recorded for velocity and torque. Immediately afterwards, a muscle biopsy was 
taken from the vastus lateralis that would be analyzed for MHC content utilizing SDS-PAGE 
separation (IIX = 13.8±12.9%, IIA =49.5±10.3 %, I = 36.8±11.3%). Data analysis of vertical 
jump and leg extension performance was analyzed for a number of variables. Results: 
Significant relationships were found between jump peak and mean power relative to cross 
sectional area of the thigh with type IIX fiber (r = .429-.459*)(*  = significance p <.05). Negative 
relationships were noted with vertical jump height and type I fiber (r=-.355*), velocity load slope 
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and intercept to type IIA fiber (r=.377-.480*), predicted peak and mean power maximum to type 
IIA (r=-.328-.352*) and type I fiber (r=.314*), and mean velocity fatigue index to IIA fiber (r=-
.319*). Conclusion: This research further establishes a number of links joining exercise 
performance to muscle MHC, and promotes further research linking muscle MHC to 
performance at varying resistance levels along the potential load spectrum for skeletal muscle.  
Key Words: Vertical Jump, Myosin Heavy Chain, Muscle Fiber type, Leg extension 
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Chapter 1 - Problem 
Introduction 
 Of the contractile tissue in the body, skeletal muscle is the only under volitional control. 
Without muscle mass daily tasks as basic as locomotion are impossible. Having a large amount 
of muscle mass has been shown to increase survivability and independence in an elderly 
population. However, not all muscle is the same and there are a variety of fiber types in humans. 
Although they all share the same basic properties of contractility, there are a number of 
differences in fatigability, force, and power production. The three primary fiber types are type I, 
IIA, and IIX (sometimes called IIB). Type I fibers are “slow twitch” fibers, which are not only 
the most fatigue resistant, but also have lowest power production. Type IIA and IIX are fast 
twitch fibers which not only have higher fatigue rates, but a greater power production, more 
specifically type IIX fibers, which have the highest power production. It is also important to note 
that humans have hybrid fibers. This is where a single muscle fiber has multiple myosin heavy 
chain (MHC) types expressed. These fibers express multiple MHC isoforms along their length. 
With training, it is possible to cause these hybrid fibers to selectively express the MHC most 
compatible to the form of training (Fitts & Widrick, 1996; Pette, 2001; Pette & Staron, 2001). 
 With these different fiber types, there have been a variety of effects seen on performance. 
Having higher amounts of type I fibers predisposes someone to be a greater aerobic athlete 
whereas having higher amounts of Type II fibers predisposes someone to be a better power 
athlete. There has been little research that has shown the positive effects of having higher 
amounts of IIX fibers on performance. It is theorized that having a higher amount of type IIX 
fibers will lead to greater power or speed performance, yet this is very hard to analyze. Previous 
studies have tried to do so with mixed results.  Some studies have shown that there is a positive 
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effect of having type IIX fibers, as they are expressed in high level sprinters (Baumann, Jaggi, 
Soland, Howald, & Schaub, 1987), but still more research must be performed in this area. 
However, high numbers of IIX fibers are also found in sedentary controls and are rarely 
expressed in well trained subjects (Fry, Schilling, et al., 2003; Fry, Webber, et al., 2003). Some 
have seen a decrease in the expression of the type IIX fibers in the skeletal muscle with training 
(Andersen, Klitgaard, & Saltin, 1994; Trappe et al., 2000).  This is due to a conversion of fiber 
type in hybrid fibers to IIA or I fiber types (Staron et al., 1994). There has yet to be a study that 
has shown a high amount of type IIX fibers in well trained subjects of a large sample size, more 
specifically not in hybrids utilizing myosin ATPase techniques (Pette, 2001).  There is limited 
research linking IIX concentration to vertical jump performance, specifically in the depth jump 
(Eckerson, 2005; Fry, 2002).  
In order to measure muscle fiber type, it is necessary to take a muscle biopsy, which is an 
invasive procedure (Staron et al., 1990). There are a few studies that have developed models or 
shown relationships between muscle fiber type and performance on different muscle tasks. 
However, these tasks typically require expensive equipment or measurement tools. Furthermore, 
these methods typically end at attempting to quantify the difference between heavy chain fast 
and slow fibers, without differentiation between the two fast isoforms of IIA and IIX (Herda et 
al., 2010; MacIntosh, Herzog, Suter, Wiley, & Sokolosky, 1993; Sadoyama, Masuda, Miyata, & 
Katsuta, 1988; Schilling, Fry, Chiu, & Weiss, 2005; Schilling, Fry, Weiss, & Chiu, 2005; 
Thorstensson, Grimby, & Karlsson, 1976). Being able to mechanically test subjects for fiber type 
conversion is of importance and should be evaluated.  
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 Purpose 
The purpose of this research study is to explore exercise performance relationships with 
muscle fiber type, specifically IIX during isotonic and plyometric exercises. 
Rationale and experimental approach to the problem 
By creating a predictive model for muscle MHC a glimpse into potential reasons for 
certain athletic performances, and allow researchers to create MHC composition estimates 
without the need for muscle biopsies. Furthermore, a predictive model will hopefully allow the 
test to be performed in a setting that utilizes less cost prohibitive equipment and to be performed 
and analyzed more easily (Baguet et al., 2011; Herda et al., 2010; Thorstensson et al., 1976). 
 Independent and dependent variables 
To create a predictive equation to estimate muscle MHC, a number of variables were 
tracked in order to try to create a model which remained accurate for a number of subjects with a 
variety of genetic predispositions and training backgrounds. Individuals with different training 
backgrounds were divided into groups based upon self-reported exercise health histories. The 
four groups subjects were allocated into were:  
Resistance trained – These subjects were capable of back squatting at least 1.5x their own 
body weight in the barbell back squat.  A squat was defined as to top of the thighs, (quadriceps) 
parallel to the ground.  They utilized the stance of their own preference (which was be measured 
and documented for consistency throughout the study), with a belt and no knee wraps. 
Endurance trained – These subjects were capable of running a mile in less than 6 minutes 
and had a total weekly running volume of 30 miles or more. Subjects that are cyclists or other 
type of aerobic athlete were evaluated on a case by case basis. 
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Recreationally trained – These subjects were active most days of the week and not 
following an organized, periodized, resistance training program or aerobic program. Subjects 
were not able to run a mile in less than 6 minutes and squatted less than 1.5x bodyweight. Final 
judgment on inclusion in this group was reserved for the research team. 
Sedentary – These subjects did not take part in any exercise program or sports for at least 
2 years prior to the study. They also did not participate in more than 2 hours per week of 
exercise. 
Other independent variables include subject MHC characteristics (determined through 
muscle biopsies and analyzed utilizing SDS-PAGE gel electrophoresis methodology), muscle 
cross sectional area, and lean body mass. Subject performances on isotonic and isometric leg 
extension tests and performance (power, impulse, and rate of force development) in the vertical 
jump tests were the dependent variables in the study. These tests are readily available in most 
laboratories and moderately easy to perform. Specifically, the velocity and power performance 
metrics, if effectively linked to MHC, will allow for field testing of MHC that will be both cost-
effective and easy to perform. Through these parameters we showed a significant relationship 
with the relative expression of types I, IIA, and IIX MHC and performance in this research. 
 Hypotheses 
 Vertical jump performance 
 Hypothesis 1: Vertical jump impulse, rate of force development, jump height, and power 
will have a positive relationship to vastus lateralis muscle fast MHC composition, specifically 
when variables are calculated relative to body mass and cross sectional area of the muscle. 
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 Leg extension performance 
 Hypothesis 2: Isotonic leg extension velocity-load linear relationship will be related to 
muscle MHC with fast fiber positively correlated to the intercept of the line and negatively 
correlated to the slope of the line. 
 Hypothesis 3: Isotonic leg extension power-load curves will be related to IIA, specifically 
the point of which the peak occurs at; earlier peaks relative to percentage of the total load will be 
negatively related to fast fiber composition. 
 Hypothesis 4: Isotonic leg extension test fatigue index will be positively related to total 
concentration of the combination of both fast isoforms.  
Limitations and delimitations 
Delimitations 
In order to make this research study be as applicable and general as possible, there were a 
number of delimitations that were made: 
In order to control for any potentially complicating effects of having both males and 
female participants, only males were recruited to take part in this study. Subjects were healthy, 
with no major orthopedic, metabolic, or neurological diseases or disorders as a means to remove 
any possible confounding effects of utilizing subjects who might not be able to optimally express 
force or muscle recruitment. Subjects were all aged 18-35 years, to adjust for any possible effects 
of development or age-related sarcopenia that could affect muscle mass, more specifically MHC 
conversion. We recruited subjects who had a variety of training backgrounds: sedentary, 
aerobically trained, resistance trained, and recreationally trained (criteria listed earlier). By 
utilizing subjects with a wide variety of backgrounds we hoped to obtain varied muscle fiber 
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expression. This wide –range of fiber expression and physical capacity allowed for more variable 
exercise performance.  This allowed the research team a greater opportunity to find significance 
and decreased the amount of subjects required for participation in the study. 
There is an extensive amount of muscle groups in the body, but we only related the tests 
to the quadriceps and biopsied the vastus lateralis. This allowed examination and performance 
measures to be focused on this muscle.  The vastus lateralis was chosen, as it is a very large 
muscle, and is easy to test and biopsy, with only a minimal risk for complications. By utilizing a 
large muscle group, we had the advantage of working with greater force and power production. 
The higher variability of the data collected provided greater versatility and relation to 
performance. Follow up studies could potentially examine the effect in other muscle groups, but 
first a relationship must be found in this study to justify another. 
We quantified the proportion of MHC through homogenized samples run through SDS-
PAGE page. There are a number of different ways to perform this type of examination, but we 
were solely interested in linking performance to present MHC expression it was not necessary to 
complete myosin ATPase staining. ATPase analysis would have shown the same type of results 
that we obtain through only the MHC SDS-PAGE, and also provided the proportion of hybrid 
muscle fibers, fiber number, and fiber size, which is not of added interest in this study. 
With the Biodex, we performed isotonic testing, and no isokinetic testing. By utilizing 
isotonic testing, we were able to generate results that allowed for greater application of the 
protocol. The reasoning for this is to lower needs for specialized equipment and invasive tissue 
collection so that this can be developed into a field test for MHC. This will be more useful to the 
practitioner as a means to quantify MHC in subjects, athletes, or clients. 
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Assumptions 
We assumed that all of our subjects would give their best effort on each test. We 
anticipated that subjects would not prematurely fatigue during the power load test, which would 
affect final results. Subjects informed researchers if they were ill or had any other type of 
problem that would decrease exercise performance on any given testing day (trained the day 
before).  
We assumed that the distribution of MHC throughout the muscle did not vary too greatly 
along the length of the muscle, so that our muscle biopsy would construe a representative sample 
of the subject’s true MHC. We assume that by performing the biopsy on the same biological 
landmark for each subject will further help control for variability on the biopsy. We also 
assumed that there would not be enough training days to cause significant MHC shifting in the 
subjects. Furthermore, that there would not be significant neurological adaptations to the exercise 
that would change the effectiveness of the tests with the subjects.  
All of our equipment was calibrated accordingly to give us accurate and reliable data. 
Our method of heavy chain analysis was consistent and the means of quantifying our results was 
accurate and reliable. 
Definitions 
Isoforms – This is slight variations on the same base structure. In reference to human 
muscle, these slight variations cause differences in speed of contraction and shortening rate. This 
can also effect power production. 
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Velocity-load curve – This is a typically linear relationship between maximal velocity 
attained with a given load. As load increases, peak velocity decreases. This relationship varies by 
individual. 
Power-load curve – This is the 2
nd
 order polynomial relationship between maximal power 
attained at a given load. As load increases, power will peak and then decline as a subject gets 
close to their max. This relationship is different from individual to individual. 
One Repetition Maximum (1RM) – This is the greatest amount of resistance that can be 
lifted for only one complete repetition in a given movement. 
 Myosin Heavy Chain (MHC) – The component of the contractile fiber that comes in 
various forms and each form as a different contraction speed and fatigability, activation of this 
protein causes muscles to contract. 
 Fatigue Index – The decline in performance of an event from the greatest performance to 
the lowest performance in trials that induce a decrease in performance. Mathematically defined 
as: fatigue index = (greatest performance – lowest performance) / greatest performance X 100. 
 Impulse – The sum of the Average force multiplied by the time of period the force was 
applied. 
 Maximal Voluntary Contraction (MVC) – The greatest amount of force that can be 
volitionally produced by subjects participating in the study against an isometric task.  
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Chapter 2 - Review of Literature 
 Basic muscle architecture and contractile units 
 In humans, contractile tissue comes in 3 different forms; skeletal, smooth, and cardiac. 
Skeletal muscle is the only type of muscle that is under volitional control of the nervous system.  
Autonomic (sympathetic and parasympathetic) innervation can affect functioning of the smooth 
and cardiac muscle; therefore it is not under conscious control and can be fully contracted and 
relaxed by other regulators. The organization of each of these muscle types differs, but only 
skeletal muscle architecture will be analyzed in this review.  
 Skeletal muscle is organized into groups of overlapping myosin and actin. Myosin and 
actin form the basic contractile unit where myosin attaches to actin and “pulls” itself along the 
actin. Individually, one head of myosin produces very little force (approximately 0.4pN
.
nm
-1
) 
(Finer, Simmons, & Spudich, 1994). However, a single myosin protein with multiple heads is 
surrounded by actin to form a sarcomere, and hundreds of these sarcomeres make up one muscle 
fiber. Not only are they grouped together laterally, but they are oriented end to end longitudinally 
along the entire muscle cell from the origin to the end point of a given muscle. When increased 
laterally (cross-sectionally), this orientation has been shown to increase force production. Simply 
put, a larger muscle is a stronger muscle.  
Description of Fiber Types 
Definitions of Fiber Types (abbreviations) 
 There is a number of MHCs (ten forms) identified in humans, and only three different 
isoforms that are found in adult skeletal muscle under normal conditions: I, IIA, and IIX. This 
review and proposal will only focus on those three in detail. Other isoforms might be mentioned, 
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but are rarely found in skeletal muscle. Those rarely found fibers are typically found only due to 
disease state, early in development, or transiently after large amounts of stress. Their abundance 
in healthy muscle is negligible for any effect on performance in healthy adults (Weiss, 
Schiaffino, & Leinwand, 1999). 
Fiber Types in Humans 
 In humans there are a number of different types of contractile tissue. The three different 
types of contractile tissue in humans are skeletal, cardiac, and smooth. Each of these fiber types 
has different kinds of arrangements, both structurally and within interactions between actin and 
myosin. These fibers also vary based upon the types of electrical action potentials and 
contraction mechanisms. This review will focus on the different isoforms of skeletal muscle 
tissue MHC.  
Throughout all of the skeletal muscles there are varying distributions of each of the fiber 
types. Some muscles are more predominantly type I (soleus), while other muscles typically 
contain higher amounts of fast twitch (both IIA and IIX) (Triceps surae) (Elder, Bradbury, & 
Roberts, 1982). Within certain muscles there is a shifting of expression in different locations 
throughout the muscle, such as the trapezius (Lindman, Eriksson, & Thornell, 1990).  Muscle 
MHC composition varies from person to person, but the manner in which an individual stresses 
the body (resistance training, aerobic training, sedentary behavior, etc.) greatly effects their 
muscle MHC composition (Simoneau & Bouchard, 1995). There is also a 20-50% genetic 
component to muscle fiber type that will be briefly visited later in this review (Bouchard et al., 
1986).  
Each of these muscle fiber types has characteristics that differentiate it from another. 
Enzymatic capacities of individual fibers are found in higher concentrations according to the 
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metabolic conditions of preference to the fiber (type I aerobic, type IIA/X anaerobic). These 
enzymatic concentrations, due to energy production, are to an extent trainable, and will increase 
or decrease in concentration according to training stimulus (Bouchard et al., 1986; Galpin et al., 
2012). Power production from individual fiber types is shown to be highest in IIX fibers, 
followed by IIA, and then type I fibers. Shortening velocity is shown to have the same 
relationship where IIX is the fastest and I is the slowest (Bottinelli, Schiaffino, & Reggiani, 
1991). However, total force produced, controlled for cross sectional area, is essentially the same 
for each of the fiber types. 
Beyond the MHC effects there are additional effects of the myosin light chain 
characteristics. These light chains have a variety of isomers that differ on the speed and amount 
of power production that they can create. It is also thought that these isomers might shift due to 
training, but these effects have not been thoroughly investigated and do not have as large of an 
effect as MHC characteristics can have on performance (Fitts & Widrick, 1996). 
 In human skeletal muscle samples from cadavers, the biceps brachii has an expression of 
a multitude of isoforms. Across a number of samples, slow twitch, type I fibers were found to 
also express alpha cardiac fibers, embryonic, and fetal isoforms. In fast (type IIA and IIX) fibers 
embryonic and fetal isoforms were also detected. This shows the variable expression of human 
skeletal muscle fiber, which lends to the plasticity of muscle according to the demands placed 
upon it, as well as the amount of reformation that is occurring within it (Liu, Eriksson, Thornell, 
& Pedrosa-Domellöf, 2002).  
Some of the other varieties of skeletal muscle fibers in the body are found in specific 
regions of the body such as the muscles that control the motion of the eyes. In extraocular 
muscles, a variety of MHC expression has been seen beyond that typically seen in the other 
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skeletal muscle; through immunoblots and immunocytochemistry, Kjellgren et al.  showed the 
presence of heavy chain isoforms I, IIA, IIX, embryonic, and extraocular isoform (Kjellgren, 
Thornell, Andersen, & Pedrosa-Domellof, 2003). 
 
Figure 1 (Kjellgren et al., 2003) display of multitude of MHC separation utilizing SDS-
PAGE methods 
When older men (over 70) were immobilized for 3.5 months, neonatal MHC was found 
to be expressed in samples from their vastus lateralis. This isoform was found in none of the 
other subjects (healthy, non-immobilized old, or young), and is linked to disuse of the muscle. 
The same sample from the immobilized group also had much higher amounts of hybrid fibers 
than the other groups sampled in the study (D'Antona et al., 2003). 
Note on Fiber Type Names 
There is some debate in the nomenclature of the IIX fibers that are sometimes labelled 
IIB/D (Staron, 1997). In the animal model, there are more than 3 heavy chain isoforms that are 
found expressed in skeletal muscle (Bottinelli et al., 1991; Termin, Staron, & Pette, 1989), 
however, in mature human skeletal muscle only I, IIA, and IIX are observed. The debate over the 
labelling arises from genomic similarities and translation that occurs since the sequence does 
closely resemble animal IIB in the mRNA sequence (Smerdu, Karsch-Mizrachi, Campione, 
Leinwand, & Schiaffino, 1994).  
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Muscle Fiber Type Variability 
In human skeletal muscle, aside from having variable expression of MHC between 
different muscles in the human body (Johnson, Polgar, Weightman, & Appleton, 1973), there is 
also variability of expression throughout the length of a muscle. Research in this area, which 
compared biopsies to full muscle excision from cadavers resulted in a correction equation listed 
in Figure 2 (Elder et al., 1982). This equation indicating that the  mean percentage of fast twitch 
fibers (both IIX and IIA) equals the mean portion of the number of sites (n) with number of areas 
counted on each site (m) would have a standard error where (σ
2
w) within site variance and (σ
2
b) 
between site variance. Essentially, the greater number of biopsy sites taken and fields viewed 
utilizing ATPase techniques the lower the potential standard error. Overall, this study found that 
a single biopsy of the vastus lateralis could have a nine percent standard deviation of the total 
fast twitch fiber percentage with only one field observed which decreases to just over seven 
percent when up to 10 fields are observed (Elder et al., 1982). 
  
Figure 2 Elder et al., 1982 -  generated standard error equation based upon number of 
fields viewed per biopsy and number of muscle biopsies performed 
There is some variability in muscle fiber expression based upon the depth that samples 
are taken from. Superficial fibers tend to have a greater expression of IIX fibers compared to 
deeper fibers, which tend to have a greater expression of type I (Dahmane, Djordjevič, Šimunič, 
& Valenčič, 2005). As individuals age there seems to be an increase of this variability, 
potentially due to selective atrophy of type II fibers (Lexell, Henriksson‐Larsén, Winblad, & 
Sjöström, 1983) 
14 
 
Fiber Type Transitioning 
Skeletal muscle fiber has a high degree of plasticity. It adapts to greater working 
demands by increasing its energy producing enzyme concentration (Borges & Essen-Gustavsson, 
1989), and increasing the number of cell nuclei (MacDougall, Elder, Sale, Moroz, & Sutton, 
1980), and mitochondria (Hoppeler et al., 1985).  Skeletal muscle fiber can also alter the MHC 
composition through gene expression (Vechetti-Junior 2013); this adaptation has been observed 
in humans and animals. 
There is a variety of research conducted with rats showing adaptations in MHC to 
different stimuli. This model has also shown intracellular mechanisms behind both genetic and 
intramuscular signals for fiber type transitions. In Wistar rats, just 8 weeks of swim training 
increased type IIA fiber in soleus (decreased type I) and plantaris (decreased type IIX) muscles. 
This fiber transition activated the NFATc1-3 gene expression, which is specific to fiber type 
expression, yet did not activate the NFATc4 level or calcineurin expression (CaN) (Vechetti-
Junior 2013). Other animal research has utilized nerve blocks and chronic electrical stimulation 
of musculature. This research has shown a significant conversion of fast fiber muscle to include 
greater amounts of type I fiber. However, in slow twitch, dominant muscles there was not a 
significant increase in fast fiber (specifically B) (Termin, Staron, & Pette, 1989). 
In humans, shifting of muscle fiber type can occur after a moderate amount of time with 
consistent application of stress. 10 weeks of circuit weight training decreased the proportion of 
type IIX fibers in sedentary individuals (Harber, Fry, Rubin, Smith, & Weiss, 2004). Loads in 
this training protocol were typically between 40 and 60% of the subjects 1RM, which showed 
that low intensity circuit training was capable of decreasing IIX concentration. There have also 
been studies which have shown a decrease in type I fibers and an increase in type IIA muscle 
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fibers during 6 week stretch shortening, cycle power training in addition to resistance training. 
(Liu, Schlumberger, Wirth, Schmidtbleicher, & Steinacker, 2003). 
Longer training studies, utilizing untrained individuals, have shown an increase in type 
IIA fiber and a decrease in IIX proportion, specifically a decrease in hybrid fibers, which likely 
shifted to present more IIA throughout the fiber, as opposed to multiple isoforms. This 
adaptation occurs in both sexes (Staron et al., 1990; Williamson, Gallagher, Carroll, Raue, & 
Trappe, 2001). Few studies have shown how fiber type adapts to training and then regresses with 
detraining.  Anderson and Aagaard had subjects first participate in 3 months of resistance 
training, which showed a decrease in the proportion of IIX muscle fibers and an increase in the 
amount of IIA fibers. Following this phase, subjects then completed 3 months of detraining. 
Following detraining, subjects actually experienced an increase in IIX fibers to a higher 
proportion than they had experienced during their baseline (Andersen & Aagaard, 2000). In older 
men, 12 weeks of moderate resistance training decreased the amount of hybrid fiber expression 
and increased the concentration of type I muscle fiber. However, no significant change in the 
total concentration of pure IIA or IIX fibers was observed (Williamson, Godard, Porter, Costill, 
& Trappe, 2000). This training response has been seen in athletic populations that are well 
trained. For example, female soccer players taking part in a strength training program 
experienced a decrease in the amount of their type IIA fiber area compared to soccer players who 
did not take part in the resistance training protocol (Andersen, Klitgaard, Bangsbo, & Saltin, 
1994). 
Sprint trained, older individuals experience a decrease in type IIX expression, but no 
decrease in amount of IIA as they age. This is potentially a training adaptation; the use of the 
fibers caused them to maintain function. Skinned fibers in the study maintained the same 
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velocity in both older and younger individuals (Korhonen et al., 2006).  Women, specifically, 
experienced a decrease in power production in type IIA fibers with aging.  Yet the same effect 
was not seen in older men (matched for adequate activity levels) when compared to young, 
active, men and women (Miller et al., 2013). This is an area that warrants further exploration, 
due to the fact that women during this generation had significantly less access to athletics at a 
younger age. This lack of athletic opportunity could be a contributor to the decrease in the 
muscle fiber functionality. 
In sprinters who underwent a hard training protocol, researchers have seen a decrease in 
both type I and IIX concentration, with an equivalent increase in the IIA isoform. The greater 
decrease was seen in the type I, however, hybrid fibers were ATPase stained with still moderate 
amounts of IIX with IIA expression, opposed to purely IIX fibers which were quite rare (1 in a 
1000 fibers analyzed) (Andersen, Klitgaard, & Saltin, 1994). When older sprinters took part in an 
organized resistance training program on top of their sprint training, they experienced an increase 
in type IIA fiber size, but no significant change in fiber composition or function when compared 
to age matched sprinters not in the intervention (Cristea et al., 2008). Transitions also occurred in 
athletes who were performing sprints on a bicycle, not on land. High intensity sprint, stationary, 
cycling for 15 weeks showed a  decrease in IIX concentration, an increase in type I 
concentration, as well as an increase in the fiber size in each of the isoforms (Simoneau et al., 
1985). 
Some studies do not show any significant changes in fiber type with a training 
intervention; often this is related to too brief of a training stimulus or too small of a training 
stress. One week of acute, resistance overtraining showed no shift in MHC characteristics, or any 
other significant changes in the isoform concentrations (Fry, Schilling, Weiss, & Chiu, 2006). 
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Swimmers who went through an intense, 10 day training showed no change in muscle MHC 
composition in their deltoid muscle, yet experienced a change in the shortening velocity; Type I 
muscle fibers increased shortening speed, while the type II fibers decreased their shortening 
speed. The authors theorized this could be due to opposite heavy chain expression in the muscle 
fibers related to the intensity of the training (Fitts, Costill, & Gardetto, 1989). When subjects 
performed a bike sprint protocol for 6 weeks, there was no change in the MHC composition in 
either the vastus lateralis or gastrocnemius. The training volume, however, was only composed 
of 12, 3 second sprints per week, broken up over 4 training sessions.  This volume was 
understandably inadequate to cause any shift in fiber type in recreationally trained individuals 
(Harridge et al., 1998). 
After 8 weeks of jump squat training at two different intensities, (30 and 80 %of 1RM 
load) researchers saw no significant change in muscle fiber type expression in active and athletic 
males (McGuigan et al., 2003). 54 weeks of progressive resistance training program provided no 
significant shift in MHC IIA or IIX fibers. This could have been due to lack of adherence, or 
possibly lack of sufficient training volume to induce a large enough change, since the authors did 
publish their training program it is not possible to compare the training program to other 
successful studies. An interesting note is they saw a significant, negative correlation between 
amount of time subjects spent playing recreational activities and type IIX fiber concentration 
(Puhke et al., 2006). 
 Few studies have used a mixed model of resistance training with aerobic training to look 
at MHC transition. In a training study examining fiber type change with a strength training 
program, strength and endurance program, or endurance only program, fiber shifting was seen in 
every group. Most interestingly, IIX fibers were no longer found in the strength and endurance 
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group only. The resistance training group had an increase in the amount of hybrid I/IIA fibers, 
while the endurance group had an increase in type I fibers (Putman, Xu, Gillies, MacLean, & 
Bell, 2004). 
Not only does MHC adapt in human skeletal muscle, but this adaptation can also been 
seen in the other contractile tissues. In the heart, fiber type transition from the alpha (which is 
more powerful isoform) to the beta isoform of MHC occurred in end stage heart failure (Miyata, 
Minobe, Bristow, & Leinwand, 2000). In individuals with cardiac failure, there was not only an 
increase in IIX concentration, but a decrease in type I concentration  The degree to which this 
occurs is outside the realm of a mere training effect and may be a sign of a greater skeletal 
muscle dysfunction while  in heart failure (Sullivan et al., 1997). 
Finally, changes of MHC composition, though modifiable with adequate training stress, 
can regress back to baseline with the removal of the training stress. With both training and 
detraining, fiber type shifting has been seen in healthy individuals in an intervention of 3 months 
(Andersen et al., 2005). This showed a decrease in the amount of IIX fibers with training. 
However, when the training stimulus was removed for three months, levels of IIX increased 
slightly over baseline values.  
Individual Muscle Fibers and Performance 
Type II fiber types shorten at a faster rate than type I fibers in rat tissue (R. Bottinelli et 
al., 1991), specifically type IIX shorten faster than the type IIA. In humans, the same is true with 
the slowest being type I (Pette & Staron, 2000). Power production is similar with IIX being the 
highest, followed by IIA and type I. All fiber types produce nearly identical amounts of isometric 
force when standardized for cross sectional area. When it comes to fatigue resistance and 
metabolic enzyme concentrations, type I fibers have the greatest fatigue resistance and aerobic 
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capacity, followed by IIA, which are well adapted for anaerobic glycolysis, and then by IIX, 
which have limited metabolic capacities and fatigue the most quickly (Trappe et al., 2004; 
Trappe et al., 2000).  
Myosin light chain isoforms also effect muscle shortening velocity and help to explain 
some of the variation in shortening velocity within MHC fiber types. This can assist in 
explaining the overlap, specifically in the shortening velocity of Type IIA and IIX (Bottinelli, 
Betto, Schiaffino, & Reggiani, 1994). The speed that muscle fiber contracts is independent of the 
muscle it comes from, however the type of heavy chain and light chain that is expressed causes a 
difference in contraction velocity and power production (Sweeney, Kushmerick, Mabuchi, 
Sreter, & Gergely, 1988). To date, five different isoforms have been identified and their 
distribution varies in each heavy chain fiber type (Staron & Pette, 1987a, 1987b). 
Metabolically, type I fibers have the greatest concentration of oxidative enzymes 
compared to both of the fast isoforms (Type IIA and IIX), which have greater amounts of 
glycolytic enzymes. Type II fibers have a greater amount of myokinase concentration than type I 
fibers as well (Borges & Essen-Gustavsson, 1989). The greater amount of aerobic enzymes in 
type I fiber lends individuals with high percentages of type I to have an advantage with 
endurance activities and tests. Along with knee flexor endurance, and knee extensor strength, the 
percentage of type I fiber explained 40% of variance in VO2 performance during a cycling test 
when analyzed utilizing a stepwise regression (Segerstrom et al., 2011). 
When it comes to varied expression of MHC characteristics, studies with well-trained 
subjects have  shown very little to no IIX expression when compared to sedentary subjects (Beck 
et al., 2008). Strength athletes, such as weight lifters and power lifters, have greater amounts of 
hypertrophy of their type II fibers (both A and X) compared with body builders, who have equal 
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amounts of hypertrophy of their type I and II (both isoforms) fibers. This is likely a training 
effect since weight lifters and power lifters consistently train at a higher percentage of their 1RM 
(Fry, 2004). 
Space Flight 
After 11 days of space flight, the concentration of type I fibers significantly decreases, 
while there is an increase in both type IIA and IIX fibers in the muscles of the calf (Trappe et al., 
2009). There was no significant shift to one of the fast isoforms or the other (Zhou et al., 1995). 
Hyperplasia 
Another possible cause for muscle hypertrophy and an increase in muscle fiber 
concentration in any one of the isoforms is hyperplasia. This is when satellite cells divide and the 
daughter cells become contractile muscle fibers that are then innervated, and then used by the 
muscle or continue to divide. This type of occurrence has not been directly documented in 
humans and is unlikely to occur to any significant level (Abernethy, Jürimäe, Logan, Taylor, & 
Thayer, 1994). This however, does not mean it does not occur. In the animal model, it has been 
shown to transpire in both mammalian and avian species (Antonio & Gonyea, 1993). 
Specifically, more in birds than  mammals, and can be caused by a large, stretching stress or 
intense training (Kelley, 1996). Stretching has been shown to cause a greater degree of 
hyperplasia than training (Kelley, 1996). 
Only a few studies have had results that suggest the occurrence of hyperplasia in humans. 
In male subjects who participated in 12 weeks of hard resistance training, muscle biopsies were 
performed before and after training. Utilizing myosin ATPase techniques, their increases in cross 
sectional area for the muscle could not be explained by only the increases in fiber size for the 
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type I and II (both isoforms). This increase in the cross sectional area was attributed to the 
possibility of hyperplasia having occurred (increase in fiber number); however this theory was 
unable to be confirmed. What is also of interest in this study is the capillary density of both the 
muscle fiber types increased with the training protocol (McCall, Byrnes, Dickinson, Pattany, & 
Fleck, 1996). 
Finally, the possible mechanism for how this occurs in humans has been identified to a 
limited extent in humans. By utilizing electron microscopy, subjects who participated in 6 weeks 
of aerobic bicycle training had small myofibers with central nuclei, which upon further analysis 
turned out to be myotubes. This type of formation showed satellite cells had started to fuse with 
muscle fibers, which denotes that hyperplasia was occurring to some degree in the muscle 
(Appell, Forsberg, & Hollmann, 1988). 
Effects of Training on Fiber Types 
Human muscle fibers contain a high degree of plasticity. Through training, muscle fiber 
type can start to shift towards those that it is mostly utilized for. If an individual trains for 
endurance events, there is  an increase in type I fiber concentration, and if they train for 
strength/power events, there is a shift towards a greater amount of type II fibers, specifically type 
IIA concentration (Wilson et al., 2012). There are a number of studies that have shown this 
transition in humans. 
In resistance training, specifically, adaptations in muscle fiber types can occur rapidly. In 
as few as two weeks, females participating in a twice a week resistance training program saw a 
decrease in percentage of type IIX fibers, while males with the same program, saw this change 
occur in 4 weeks (Staron et al., 1994). Fiber type shifting seems to occur no matter the repetition 
range trained, as long as there is adequate training frequency and volume (Campos et al., 2002). 
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With resistance training, an adequate amount of training stress is also required to alter fiber type 
expression. When sedentary individuals trained one leg with high intensity resistance training 
(70%) and the other leg with low intensity (17%), matched for total training volume load, there 
was no change in the expression of type IIX fibers in the low intensity group, but there was a 
significant decrease in the high intensity group (Holm et al., 2008). In subjects older than 90 
years of age, a response to resistance training is still seen, with an increase in size and strength of 
the skeletal muscle, specifically hypertrophy of the IIA fibers, and a slight decrease in type I 
fibers (Kryger & Andersen, 2007). 
Power training has shown mixed results on fiber type change with exercise. Sprint 
training can also cause a fiber type shift. With just 6 weeks of sprint cycle training, a significant 
decrease was seen in type IIX fibers, whereas no significant changes in type I or IIA 
concentration was reported (Allemeier et al., 1994). However, after 15 weeks of power training 
with moderate loads no significant changes in muscle fiber type in the gastrocnemius occurred in 
subjects (Kyröläinen et al., 2005).  
Endurance training can cause a shift in muscle fiber type as well. Gastrocnemius muscle 
biopsies from young runners showed very few hybrids (1%) and a high percentage of type I 
fibers (66%). Composition of the MHCs did not significantly change over the 12 weeks that the 
athletes participated in the study, but there was a significant increase in type I fiber size over 
baseline at 8 and 12 weeks (Harber, Gallagher, Creer, Minchev, & Trappe, 2004).  High intensity 
endurance training was shown to decrease type IIX concentration after only 8 weeks of training, 
and when comparing professional cyclists’ muscle fibers to sedentary controls they have, on 
average, 20 times fewer IIX fibers. This population had 80% type I fibers in the vastus lateralis 
(Baumann et al., 1987). 
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A combination of resistance training and endurance training can change muscle fiber 
composition and type. This change is specific to the emphasis of the type of activity and previous 
training status of the subjects. After 16 weeks of strength and endurance training, elite level 
cyclists saw a decrease in type IIX muscle fiber concentration and an increase in type IIA 
proportion (Aagaard et al., 2011). 
Some research has shown that just the act of playing a sport competitively throughout a 
season can reduce IIX fibers. Men’s hockey players experienced a decrease in IIX fiber 
concentration over the course of one season and as well as an increase in IIA fiber concentration 
(Green, Thomson, Daub, Houston, & Ranney, 1979). 
Age and Fiber Type 
As people age, there is a transition in fiber type to a greater amount of type I fiber, and a 
loss of type II (A and X) fibers (Venturelli & Richardson, 2013). These effects start to occur as 
young as age 25 and continue as we age. Specifically, there is a decrease in the number of fibers 
and type II fiber size (Larsson, Grimby, & Karlsson, 1979; Lexell, Taylor, & Sjöström, 1988). 
Additionally, the quality of older muscle fiber particularly type IIX has been found to decline 
(Narici & Maffulli, 2010). This is possibly due to the lack of utilization of this particular fiber 
type with older age individuals (Larsson & Karlsson, 1978),  yet the exact mechanism for the 
change of muscle fiber type with age has not been fully explored or understood. It is also 
interesting that not all of the loss in muscle force can be attributed simply to a decrease in cross 
sectional area. When examining a group of individuals across a very wide age range (23-80), 
only 39% of the force decline could be attributed to a loss in cross sectional area and there was 
no significant difference in muscle fiber type between the individuals or a shift with age. This 
suggests that there are underlying mechanisms for the decrease in force with aging that are not 
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limited to changes in cross sectional area and MHC shifting (Jubrias, Odderson, Esselman, & 
Conley, 1997).  
Aside from changes in MHC distribution, there is an alteration in contractile properties of 
the fibers. Older individuals have been shown to have lower force production with individual 
fibers compared to younger counterparts (Yu, Hedström, Cristea, Dalén, & Larsson, 2007), 
possibly attributed to an increase in fiber force production in single fiber studies with training in 
older individuals. These studies show us that fibers underperform what they are capable of with 
sufficient training stress (Trappe et al., 2000). Aside from exercise performance, muscle MHC, 
and  muscle fiber quality, it is important with older subjects who are experiencing a decline to 
not just review type II fiber content, but also the quality of the muscle fibers themselves (Slivka, 
Raue, Hollon, Minchev, & Trappe, 2008). We also see changes in individuals limited to bed rest 
(Andersen, Gruschy-Knudsen, Sandri, Larsson, & Schiaffino, 1999; Trappe et al., 2004) and 
astronauts (Caiozzo, Baker, Herrick, Tao, & Baldwin, 1994; Trappe et al., 2009), who have an 
increase in the expression of type IIX fibers. This increase in expression of type IIX is found to 
be related to detraining. 
There are a number of changes that occur with aging and performance of the 
musculature. Some of the causes for the change in muscle function with age are neuronal. There 
is a loss of motor nerve numbers as we age, which leads to a decrease in muscle performance 
despite branching, which to a degree causes re-innervation. However, this mechanism eventually 
slows and re-innervation is less likely (Stålberg et al., 1989). Some research has shown a greater 
concentration of hybrid muscle fiber in older individuals compared to younger, healthy adults 
(Andersen et al., 1999). This type of adaptation could be beneficial as a means of maintaining 
aerobic capacity and also the muscle power production potential that the type II fibers provide. 
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Older individuals typically experience a decline in speed of recovery and adaptation from stress. 
When younger and older men were immobilized for a short period of time, the older population 
took longer to regain original muscle size and strength compared with the younger population, 
specifically the type IIA muscle fibers (Hvid, Ortenblad, Aagaard, Kjaer, & Suetta, 2011). 
However, older individuals do show an increase in efficiency with age. They have a greater 
concentration of type I fibers, which produce less power than type IIA and IIX isoforms, but are 
more efficient with energy substrates, which allows for less metabolic stress on their body 
(Venturelli & Richardson, 2013). A decrease in hybrid fibers in the biceps, specifically fibers 
that express both IIA and IIX isoforms, (Klitgaard, Zhou, et al., 1990) has also been noted. Aside 
from a decrease in total amount of fibers, size, and MHC, researchers have seen a decrease in 
certain intracellular enzymes related to metabolism. Lower amount of citrate synthetase (CS) are 
present in older individuals when compared to younger individuals, which effects maximal 
oxygen consumption performance, as CS concentration is positively correlated with this measure 
of cardiovascular fitness (Houmard et al., 1998). 
As humans age the risk of developing sarcopenia increases, as does the risk for further 
compounding effects of sarcopenic obesity. Sarcopenia is a loss in skeletal muscle mass, and 
underline causes continue to be studied.  Disuse is one cause of sarcopenia, along with 
mitochondrial oxidation and exhaustion of muscle satellite cell reserves. Sarcopenic obesity is 
the associated increase in fat mass and reduction of muscle mass. This can affect metabolic 
function,  and lead to metabolic diseases, such as type II diabetes mellitus (Narici & Maffulli, 
2010). 
Older individuals do still adapt to exercise, but a variety of training studies have shown 
that these changes are often different than the adaptation that occurs in younger individuals. With 
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three to four sessions per week of aerobic exercise for 12 weeks, older women (approximately 70 
years old) increased their muscle function, specifically their type I fiber size and content. There 
was also a decrease in the expression of type IIA and IIX fibers in the mRNA expression and 
protein levels (Konopka, Trappe, Jemiolo, Trappe, & Harber, 2011). Three groups of subjects: 
young, middle-aged, and older, who took part in a resistance training program for 3 months, had 
their mRNA analyzed for each of the specific MHC isoforms, and found that older individuals do 
not transcript as high of levels of type II fibers (either isoform). The older individuals did show 
an increased expression of type I fiber, indicating that there is still adaptability to training 
stimulus later in life, however without the same expression of the fast isoforms as occurs during 
youth and middle age (Balagopal, Schimke, Ades, Adey, & Nair, 2001). Other research has also 
shown that skeletal muscle fibers still maintain adaptability in older individuals. With the use of 
a progressive resistance training program, older men were able to increase the shortening 
velocity and power of their type I and IIA fibers. There was a larger change in the type I fibers 
than the type IIA (Trappe et al., 2000). With progressive resistance training in older men and 
women (mean age of 68) there was significant increases in type I muscle fiber size after 15 
weeks of training as well as a significant increase in type IIA fibers after 30 weeks. The earlier 
significance of type I fiber size, and later increase in IIA fiber size further solidifies that type I 
fibers are more adaptable in older individuals (Pyka, Lindenberger, Charette, & Marcus, 1994). 
Older men (average age of 82 years) were put through a resistance training program for three 
sessions maximum per week over a period of 12 weeks.  Researchers found no significant 
changes in muscle MHC composition or contractile abilities. This could potentially be due to the 
low training volume, or perhaps due the greater age of this population, as multiple studies with a 
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slightly younger population and greater training volume have shown a change (Slivka et al., 
2008). 
Not all age-related muscle declines are necessarily going to occur. Those individuals, 
who trained consistently over their entire life, are able to better maintain their muscle fiber and 
performance compared to sedentary, older individuals. Older men who had been active for over a 
decade in running, swimming, or resistance training had higher amounts of type I fiber than 
younger sedentary individuals (Klitgaard et al., 1990). Older male sprinters, when compared to 
younger male sprinters, had lower amounts of type II fibers specifically type IIX, however, their 
functional strength and power of the type IIA fibers were still at the same level as the fibers 
found in the younger individuals. A longitudinal, consistent, training modality seems to lead to 
better preservation of function in specific fibers, suggesting a use of sprint training for 
maintaining type IIA fibers (Korhonen et al., 2006). 
Performance and Fiber Types 
 With large differences in energetic and power performance between the different fiber 
types in humans, it is important to look at how these effects compound in vivo. A number of 
studies with varying levels of control have looked at the effects of different proportions of fiber 
type on performance in a variety of tasks. These tasks will be broken down into muscle action 
performed and the increasing number of joints involved. 
In Vitro 
 When muscle fibers are isolated from the organism, direct measures of force, time to start 
of force production, and shortening velocity are measurable. In general, there is little difference 
in peak force production between any of the MHCs (when controlled for cross sectional area), 
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however the rate of which contraction occurs and calcium sensitivity differs between each of the 
isoforms (Fitts & Widrick, 1996). Studies have shown that twitch time to peak torque, maximal 
rate of torque development, frequency response, and fatigability are related to muscle MHC in 
the type I, IIA, and IIX (Harridge et al., 1996). The same effect was found when looking at rat 
skeletal muscle where both the IIB and IIX fibers had a greater contraction power production 
(Bottinelli et al., 1991). The same study also found that force production per unit of cross 
sectional area was higher in the type II fibers than in the type I, and it was not differentiated to 
the different isoforms of the type II.(Bottinelli et al., 1991) 
 With disuse, there is a decrease in the force produced by individual muscle fibers across 
both MHCs with immobilization. There is also an age-dependent decrease in calcium sensitivity, 
specifically a decrease in type I fibers in the young and type IIA fibers in the old (Hvid et al., 
2011). In older women, there was no reported difference in force production in either type I or 
type IIA fibers compared to younger women (Raue, Slivka, Minchev, & Trappe, 2009). There 
was a significant difference in adaptation to progressive resistance training.  Older women were 
not able to adapt to the exercise protocol\, whereas the young women were. 
Single Joint 
 Single joint movements allow all of the muscle shortening to cause rotation only across 
one joint. This joint can either stay stationary or move at a variety of velocities. Each of these 
actions can illustrate different attributes of muscle performance and will be analyzed for their 
effectiveness at estimating muscle MHC. 
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 Isometric 
 When attempting to predict muscle MHC it is important to minimize the number of joint 
actions and muscles involved in order to remove as many confounding factors as possible. One 
way to do this is to utilize single joint movements so that all of the action of the joint is caused 
by a limited number of muscles. Specifically, when looking at basic hinge joints, such as knee 
extensors, it is relatively easy to gauge muscle action of the large muscle group, the quadriceps. 
This muscle group, in healthy individuals, is a large muscle that is relatively easy to not only test, 
but biopsy (vastus lateralis portion). Current research has analyzed the quadriceps from a variety 
of approaches. One such approach is to test muscle isometric force production analyzing 
different features of this muscle action (Clarkson, Kroll, & Melchionda, 1981; Herda et al., 2010; 
Schilling, Fry, Chiu, et al., 2005; Viitasalo & Komi, 1978).  
This type of research has a variety of results that are conflicting. A research study strictly 
looking at maximal force produced found no relationship between muscle strength and fiber 
composition. Additionally, the muscle strength to cross sectional area ratio did not have a 
relationship to MHC either (Maughan & Nimmo, 1984). This study, though good for its time, 
would now be able to generate more information due to increased access and technological 
advancements. This study did help researchers to see that in isometric tests, total amount of force 
produced is not different due to variations in MHC composition. When looking at the differences 
between MVCs and fast MVCs the difference between the forces created were linked to the 
proportion of fast fiber and this link was stronger in older individuals (Clarkson et al., 1981). 
Schilling et al. found that IIX fibers, when added to a correlation model, explained a significant 
amount of the relative peak force (19.9%). This research also showed that there was trend 
towards significance on the effects of the type IIX fibers in the first half of the rise phase by 
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force produced during the MVC (Schilling, Fry, Chiu, et al., 2005). One study found a positive 
relationship between isometric MVC force and slow twitch fiber concentration, which is contrary 
to most of the research that is found in this area (Kroll, Clarkson, Kamen, & Lambert, 1980). 
Other research has examined the relationship between peak force development and MHC 
composition. The rate of which peak force was attained was related to the proportion of slow 
twitch MHC. Specifically, individuals with longer times to peak force typically had a greater 
amount of slow twitch (type I) muscle fiber in the vastus lateralis (Viitasalo & Komi, 1978). 
Further research has agreed with the positive correlation between time to fatigue in isometric leg 
extension tests and concentration of type I muscle fiber (Hulten, Thorstensson, Sjödin, & 
Karlsson, 1975). Tesch and Karlsson reported that there is a positive correlation between MHC 
characteristics (percent fast twitch fiber) and maximal isometric strength (Tesch & Karlsson, 
1978). 
Other research which compares different types of well-trained individuals has shown 
MHC specific results. When comparing sprinters to marathon runners in performance on an 
isokinetic leg extension test it was found that there was a positive relationship after correcting for 
cross sectional area for type IIA fiber area and peak torque, instantaneous power, integrated 
EMG, and contractional work at specifically a contraction speed of 180 degrees per second 
(Johansson, Lorentzon, Sjöström, Fagerlund, & Fugl‐Meyer, 1987). 
Mechanomyography (MMG) and Electromyography (EMG) 
MMG and EMG are methods of looking at muscle function. MMG can measure the rate 
at which a muscle is vibrating due to active contraction. EMG can show the amount of electrical 
activity that is occurring in the muscle due to muscle recruitment, specifically depolarization of 
the tissue. Complex systems now are able to differentiate between motor firing rates of 
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individual motor units and interrelate this to muscular function with the use of MMG signals. 
This method requires the use of isometric testing currently to assure the degree of accuracy, 
representation, and muscle recruitment. 
MMG has been used to find differences in muscular performance between the different 
MHCs. The speed of a fiber’s electrical conduction measured during an MVC has been shown to 
be related to muscle MHC. Fast isoform (IIA and IIX) skeletal muscle has a higher speed of 
conduction than slow twitch, dominate muscle fiber  (Sadoyama et al., 1988). When subjects 
performed ramped contractions, EMG mean power, frequency, and MHC were positively 
correlated. There was also a negative correlation between type I fiber concentration and the 
torque – mean power frequency intercept (Gerdle, Henriksson-Larsen, Lorentzon, & Wretling, 
1991). 
Different types of fatiguing protocols and muscular tracings have been used as a means to 
compare muscular function for MHC characteristics. Beck et al. found that when performing 45 
second isometric contractions at 50% of MVC there was no significant difference in the MMG-
EMG signals from a resistance trained or aerobic trained group to predict muscle MHC (Beck et 
al., 2009b). There was trending toward differences in mean power frequency performance, but 
due to the small sample size the difference was not significant (Beck et al., 2009a). Previous 
research showed no relation to MMG amplitude and torque production utilizing a ramping 
protocol with three different sample groups of strength trained, aerobic trained, and sedentary 
individuals (Beck et al., 2008). Herda et al., utilizing a ramp contraction from 5% to 90% of 
maximal voluntary contraction, found there were significant differences in the slope derived 
from linear regression lines created by log transforming the EMG data. This data was related to 
the muscle MHC differences in the three groups tested (resistance trained, aerobically trained, 
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sedentary). The intercept seemed to be more related to the level of subcutaneous fat (Herda et al., 
2010). 
Isotonic 
 Isotonic muscular tasks cause joints to move through a range of motion against a constant 
load. When greater forces are applied, the joint is able to move at greater velocities once the 
required force to initiate movement is overcome. Some research studies have looked at isotonic 
exercise performance as an indicator of muscle MHC characteristics. When subjects gave their 
greatest velocity/force effort against a fixed load relative to their 1RM on the leg extension 
machine at either 40% or 70%, there was no relationship to muscle MHC, possibly due to the 
small sample size (Schilling, Fry, Weiss, et al., 2005). Other research looking at  isotonic leg 
extension performance found that repetitions to failure at different percentages of a subjects 
1RM were not predictive of muscle MHC (Rodriguez, 2005). 
Further research has examined relationships between velocity, power production, and 
MHC. A positive relationship between peak acceleration and MHC has been seen for fast twitch 
(both A and X) percentage (r=.40, p=.04) with an unloaded leg extension test. There was no 
difference in the peak velocity between the subjects of differing muscle MHC compositions 
(Houston, Norman, & Froese, 1988). When subjects were divided by MHC, an isotonic leg 
extension showed that large power outputs at matched relative loads were different between the 
two groups. Individuals with higher amounts of fast twitch fiber (no differentiation between IIA 
and IIX) had greater power productions than slow twitch dominant athletes (Tihanyi, Apor, & 
Fekete, 1982). Tihanyi, found that higher powers, created along with higher velocities, were 
achieved at higher loads in individuals with a higher amount of fast twitch fiber proportion than 
their slow twitch counterparts (Tihanyi et al., 1982). 
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Multi joint 
Vertical Jump 
When subjects performed vertical jump testing there was a greater amount of stored 
kinetic energy in subjects with larger amount of fast twitch muscle fibers (type IIA and IIX) 
compared to those with more slow twitch (type I). When a longer pause occurred the difference 
in stored force dissipated, then shifted to giving a greater efficiency of force return in the slow 
twitch dominate subjects (Bosco, Tihanyi, Komi, Fekete, & Apor, 1982). Other vertical jump 
tests have shown that jump height, average force, net impulse, and average power all were 
significantly related to fast twitch fibers in a static start jump; additionally jump height and net 
impulse significantly related to fast twitch fibers in a counter movement jump. This study 
however, did not disseminate between type IIA and IIX fibers (Bosco & Komi, 1979). The only 
research found in this area looking at type IIX has been presented as an abstract (Eckerson, 2005; 
Fry, 2002) 
In athletic populations, relationships between MHC and jump performance have also 
been seen. When track and field athletes performed a vertical jump power test for 60 seconds the 
first 15 seconds of the test’s power output correlated strongly with fast twitch fiber concentration 
(r = 0.86, p < .005). After the first 15 seconds, the following 15 seconds still had some 
relationship to fast twitch concentration, but were no longer significantly related after 30 seconds 
(Bosco, Komi, Tihanyi, Fekete, & Apor, 1983). With Olympic weight lifters, there was a 
positive correlation with proportion of IIA fiber and weight lifting and vertical jump 
performance. There was not a significant relationship to performance with the type IIX fibers 
(Fry, Schilling, et al., 2003). 
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When subjects performed a fatiguing protocol, the store and return of elastic energy was 
greater in slow twitch dominant subjects before having to undergo 60 seconds of continuous 
jumping. This relationship then changed and a greater return of elastic energy was seen after the 
fast twitch fibers. (Bosco et al., 1986). Finally muscle damage from plyometric exercise has been 
shown to induce a greater amount of tissue damage to the fast isoforms compared to slow twitch 
fiber (Macaluso, Isaacs, & Myburgh, 2012), which could show both more activation and greater 
predisposition for fiber damage in the fast isoforms. 
 Wingate 
Other multi-joint, but controlled tests, have been used to predict muscle MHC; 
specifically anaerobic power tests. Utilizing an anaerobic, 30 second Wingate test a positive 
relationship was seen between peak power, total work, and power decrease with fast twitch fiber 
percentage (Bar-Or et al., 1980). This effect was found only in the male subjects, not the 
females; this was attributed to the high resistance level for females (Froese & Houston, 1987). 
Further research with a Wingate has shown relationships between the % fast twitch and peak 
power, max peak torque, and power decrease. The same study found that sedentary individuals 
did not show a significant relationship and that a 40m sprint speed was positively related to fast 
twitch percentage while a 2000m speed was negatively related to fast twitch percent (Inbar, 
Kaiser, & Tesch, 1981). 
Isokinetic 
 Specific machines have been designed to limit the speed at which a movement can occur. 
This type of exercise machine is referred to as an isokinetic device.  If a subject produces greater 
force, an internal brake is applied so that the speed of displacement or rotation cannot be 
increased over a set velocity. This testing allows for movement to be limited so subjects cannot 
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become too ballistic and possibly risk injury. Additionally, isokinetic devices allow for unique 
testing modalities with a multitude of applications. Literature has not been able to find 
significance in reference to type IIX fibers, but there are some published studies in this area. One 
research study performed by Gregor et al in 1979, found that as the isokinetic speed was 
increased, athletes with a higher proportion of type II to type I muscle fibers were capable of 
generating higher amounts of torque. This study, however, did not disseminate the contributing 
proportion of type IIX to type IIA fibers (Gregor, Edgerton, Perrine, Campion, & DeBus, 1979). 
Other articles have also come to the same conclusions regarding the correlation of fast isoforms 
(IIA and IIX) when the strength in the peak torque was produced at higher speeds of rotation on 
isokinetic leg extension tests (Coyle, Costill, & Lesmes, 1979). Further research has seen 
specific relationships with MHC and speed of movement, where no relationship between MHC 
and force production at lower speeds was seen, but one was at higher speeds (Aagaard & 
Andersen, 1998). This study did not disseminate between IIA and IIX fibers.  
The torque ratio of isokinetic leg extensions performed at 240 degrees to 30 
degrees/second was positively related to type II (A and X) fiber concentration in both males and 
females (Gür, Gransberg, Knutsson, & Larsson, 2003). The same types of relationships were not 
seen in a population of physical education students and bodybuilders. In this study, as the 
velocity of movement increased, no relationship was determined between the concentration of 
type I fibers and torque produced in the leg or elbow extension movements (Schantz, Randall-
Fox, Hutchison, Tyden, & Åstrand, 1983).  
Fatiguing leg extension tests can also be utilized for testing on isokinetic machines. One 
of the first studies to predict MHC content from isokinetic leg extension performance was 
Thorstensson. He found that a muscle with a higher amount of fast twitch fibers contracted at a 
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faster velocity. This allowed for the creation of a predictive model to look at fatigue index and 
leg extension performance (Thorstensson et al., 1976; Thorstensson & Karlsson, 1976). Other 
research has been used in high level athletes with isokinetic testing. When sprinters were 
compared with marathon runners on their performance in a fatiguing isokinetic leg extension 
test, it was found that sprinters had a much greater decline in performance, which was negatively 
correlated with their proportion of fast twitch fiber (IIA and IIX) (Lorentzon, Johansson, 
SjÖStrÖM, Fagerlund, & Fugl-Meyer, 1988). 
Sports and Fiber Type 
Muscle fiber type is linked to performance in a number of different sports. Specifically, 
sports that require one end of the power-endurance continuum tend to favor, at the highest level, 
specific MHC distributions in the athletes. Overall strength power sports tend to have elite level 
athletes with greater proportions of fast twitch fiber (e.g. sprinters) and endurance sports tend to 
have athletes with greater amounts of slow twitch fiber (e.g. marathon runners). The research in 
this area has also examined sports that require both great endurance and short bursts of power 
(e.g. soccer).  
Some research has linked MHC in athletes to performance in certain exercise tasks. 
Gregor et Al. found that the MHCs of athletes affected their performance in maximal isokinetic 
leg extension testing and that there was a positive relationship between the amount of type II 
fibers and the ability to create a greater amount of torque at a higher velocity. Furthermore, long 
distance athletes tend to have greater amounts of type I muscle fibers and sprinters tend to have 
greater amounts of type II muscle fibers, showing a specificity of MHC characteristics and 
performance. There was also a difference in the fiber size in athletes, with the fiber of most 
frequent use being larger than the other, less utilized fibers.(Gregor et al., 1979) 
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Higher amounts of type II fibers, and specifically type IIX fibers, are correlated with 
being a better sprinter, whereas Caracals had higher amounts of IIX fibers than the lions which 
still have much greater levels compared to humans (Kohn et al., 2011). In humans, sprinters tend 
to have a high amount of IIA fiber content (Korhonen et al., 2006). In weightlifting, competitors 
with higher amounts of type IIA fibers had greater performances in the lifts compared to 
competitors that had lower proportions of IIA fibers (Fry, Schilling, et al., 2003). 
Long distance runners had a higher proportion of type I fibers compared to middle 
distance runners or controls in a study by Harber et al. (Harber, Gallagher, Trautmann, & Trappe, 
2002). What is also interesting to note with this study was that the middle distance runners had 
the highest amounts of type IIA while the sedentary subjects had the highest amount of type IIX 
and hybrid fibers. This type of expression seems to be consistent with training status, and shows 
that  untrained individuals have a larger proportion of both hybrid fibers and IIX expression 
(Harber et al., 2002). Long distance athletes had high percentages of type I fibers (60-70%) 
compared to fast fibers. Type IIX fibers were found in small concentrations in the vastus lateralis 
and gastrocnemius (<6%) of the runners. This type of adaption is advantageous to the athlete 
whose sport requires continuous exercise output for over 15 minutes at a time (Saltin et al., 
1995). In a study analyzing cycling efficiency and performance, subjects with a higher 
proportion of type I muscle fiber were more efficient and performed better on exercise tests 
(Coyle, Sidossis, Horowitz, & Beltz, 1992). Cycling performance has been linked to a higher 
power output in individuals with a higher percentage of type I fibers (Horowitz, Sidossis, & 
Coyle, 1994) when matched with individuals who had comparable VO2 maxes. 
 When compared to sedentary females, female track and field athletes had a greater 
amount of type IIA fibers and a lower amount of type I fibers. Overall, there was not a 
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significant difference in the total amount of type IIX fibers in either group. This is interesting 
since the biopsy was taken 14 weeks into the training program for the track athletes and typically 
IIX fibers are less prevalent in well trained individuals than sedentary subjects. Furthermore, all 
of these athletes were national or international caliber athletes whose furthest event was the 
400m or heptathlon (Parcell, Sawyer, & Craig Poole, 2003). Female soccer players, regardless of 
taking part in a strength training program or otherwise, minimally expressed IIX fibers, and only 
expressed in hybrid fibers that also contained IIA (Andersen, Klitgaard, Bangsbo, et al., 1994). 
So far, research has shown a much greater degree of IIX fiber presence in untrained 
individuals. Not only do they present with more IIX, but it is common to have hybrid fibers 
which express both IIA and IIX isoforms. Well trained aerobic athletes tend to show a higher 
amount of hybrid fibers by expressing the type I and IIA isoforms in their muscle (Klitgaard, 
Bergman, et al., 1990). 
Genetics 
Heredity plays a factor in a person’s muscle fiber type. The MHC gene is found on the 
short arm of chromosome 17 in humans (Leinwand, Fournier, Nadal-Ginard, & Shows, 1983). 
Studies looking at twins have found genetically inherited factors to comprise about 45% of an 
individual’s fiber type (Simoneau & Bouchard, 1995). Certain genetic traits, such as being born 
with a special angiotensin-converting enzyme gene, have been seen to have a positive effect on 
having higher amounts of type I muscle fiber (Zhang et al., 2003). In older women, having 
different genetic traits has been shown to have an effect on training response. The most recent 
study specifically looked at the ACE I/D trait and ACTN3 R/X trait (Pereira et al., 2013). The 
ACTN3 R/X is related to increased amounts of fast fiber in humans, and there is still a great deal 
of research into the heritability of muscle fiber type that needs to be performed.  
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Fiber Type Analysis Methods 
 There are many different methodologies for finding MHC composition with muscle 
tissue. Each of these methodologies has their own advantages and disadvantages that must be 
appropriately analyzed to determine which fits best for the type of testing that will occur in a 
study.  
 Large format gels have been utilized in a number of studies to find the MHC 
composition. This allows for a glimpse of type fiber expression throughout the entire sample. 
Typically mounted in traganth gum to allow for an even cross section of tissue (Staron et al., 
1994). Samples are frozen in isopentane to keep from lysing the cells, which occurs with flash 
freezing in liquid nitrogen typically used in other extractions for muscle protein activation. 
Homogenate does not allow for the quantification of hybrid muscle fibers, but it shows the 
concentration of fiber isoforms relative to one another, which provides a percentage of each 
isoform present in the muscle overall (Fry, Webber, et al., 2003). SDS-page separation can also 
be done with small format gels, and has specifically been shown to work well with rat tissue 
(Talmadge & Roy, 1993). Furthermore this method has been shown to be positively correlated 
with myosin ATPase analysis (Staron, 1991). 
Single fiber (Harber et al., 2004) analysis method allows for the quantification of hybrid 
muscle MHC. This can be a useful marker due to its ability to show if fiber types have shifted, 
what fiber type is now expressed, or as a possible marker of training status (taper, in season, 
etc.). This method requires special chemical preparation to individually extract the fibers, and 
then allows for testing the fibers for force production and other variables. Fibers can then be 
lysed in an extraction buffer and ran individually, utilizing MHC large format SDS-page 
methods discussed above.  
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  Myosin ATPase staining (Baumann et al., 1987) allows for the analysis of hybrid muscle 
fiber types and for the analysis of mean fiber size, which can be indicative of training effects 
(Tesch & Larsson, 1982). This method has been available since the 1960s. By staining the cross 
sections of cut muscle fibers it allows for counting of the individuals fibers. Each fiber type 
stains to a different darkness levels depending on the type of ATPase that is expressed in that 
fiber (Bárány, 1967). Changes in fiber size overall and per fiber can be seen with this method. It 
is useful for tracking changes in expression of hybrid muscle fibers, and easily measures 
increases or decreases in their concentration.  It is, however, very time consuming since a large 
number of individual fibers must be counted in order to achieve a significant sample that will be 
representative of the rest of the muscle.(Brooke & Kaiser, 1970) 
 By analyzing the presence of the different types of MHC mRNA expression it is possible 
to start quantifying muscle fiber type transitioning at a much earlier point (Flück & Hoppeler, 
2003). This type of cellular signaling to build more protein, specifically heavy chain, can show if 
a training regime or intervention is causing fiber type to shift or maintain its current expression 
characteristics (Balagopal et al., 2001; Plomgaard et al., 2006). What is also interesting is there is 
a correlation between the mRNA expression for fiber type and for mRNA specific to different 
metabolic enzymes. This link is seen in a more aerobic enzyme mRNA expression in type I 
MHC mRNA upregulated cells, and more anaerobic enzyme mRNA expression in type II (A and 
X) MHC (both isoforms) mRNA upregulated cells (Plomgaard et al., 2006). This is sensible as 
the metabolic demands placed on the fiber would be fiber type specific. 
Western immunoblots have been utilized as a means to quantify MHC composition 
(Kjellgren et al., 2003). This method utilizes homogenized muscle samples that have been 
extracted in the same methods as the SDS-PAGE separation, but samples are transferred to a 
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receptive membrane (typically PVDF). This protein is transferred by electric current. Once 
proteins are transferred, the membrane is then washed in a blocking protein so any other possible 
binding sites are covered. At this point, the blot is then treated with an antibody that is specific to 
the protein of interest (Lucas, Kang, & Hoh, 2000). The blot is then washed and a secondary 
antibody is applied that is specific to the primary antibody. The blot is then imaged via different 
methods of chemiluminescence or scanned for infrared radiation. Imaging proteins are then 
quantified based upon image saturation and normalizing to housekeeping proteins. 
Predicting Myosin Heavy Chain Concentrations 
There are currently a limited amount of tests that are used for predicting MHC expression 
based on performance of different tasks. All of these tests have moderate degrees of ability to 
predict MHC; however, all require expensive equipment or training. The most popular isokinetic 
test currently used is the Thorstensson. This test was originally developed in the 1970’s and is 
still used today. (Thorstensson & Karlsson, 1976) When comparing fatigue indexes found from 
the testing methodology by Thorstensson et al. there was no significant differences between 
sexes, but males on average had a higher amount of peak torque (Stock, Beck, DeFreitas, & Ye, 
2013). There are also relationships between EMG and MMG signals that relate to MHC as 
mentioned before (Herda et al., 2010). Each of these methods has varying levels of ability to 
predict MHC. 
Other tests based upon resistance training are somewhat invasive, but have a limited 
amount of predictability. Lactate levels produced from heavy resistance training on a leg press 
machine were positively correlated with proportion of fast twitch fiber (both IIA and X) 
(Linnamo et al., 2000). 
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There is also more advanced technology which been used as a means to predict MHC. 
One study attempted to predict MHC characteristics of human muscle samples by utilizing 
proton magnetic resonance spectroscopy to analyze muscle carnosine levels (Baguet et al., 
2011). This predictive model was only based on looking at the difference between type I and 
both type II isoforms. 
 
Figure 3 (Baguet et al., 2011) Correlation of intramuscular carnosine levels to MHC 
content type II area  
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 Power Load Curves 
 
Figure 4 Power-load curve pilot data – displays two different subject performance on a leg 
extension performance. 
  
 Pictured above is pilot data from the lab graphing mean power performance to percentage 
of 1RM in two separate subjects (Figure 4). After graphing a best fit line, based on a second 
order polynomial agreement, there are very different performances relative to the 1RM. Best fit 
lines are given an intercept of zero for all participants. Both of these subjects were recreationally 
trained, one subject was strength trained, while the other aerobically trained. Their training 
history and performance suggests MHC differences. Deriving estimate peak performance along 
the percentage of 1RM line requires the solving of the polynomial best fit line for the greatest 
“y” value. 
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 Velocity Load linear agreement  
 
Figure 5 Velocity load linear agreement pilot data - displays two different subject 
performance on a leg extension performance. 
Pictured above is more pilot data from the lab showing the linear agreement to velocity 
performance as subjects get closer to their 1RM (Figure 5). These are the same subjects from the 
previous graph. It is possible that the different performance can be attributed partially to MHC 
differences in the subjects. This pilot data has fallen in line with the same great deal of variability 
that we have found when testing well trained athletes in the barbell back squat. 
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Chapter 3 Methodology  
Subjects  
Forty two males between the ages of 18-36 were recruited for this study. Subjects had no 
history of major medical problems or surgeries based upon self-reported questionnaires. Subjects 
were then placed in sub-groups dependent on current activity level based upon health/training 
history responses. Criteria for the groups were as follows:  
Resistance trained (n = 13) – These subjects were capable of back squatting at least 1.5x 
their own body weight in the barbell back squat.  A squat was defined as to top of the thighs, 
(quadriceps) parallel to the ground.   
Endurance trained (n = 12) – These subjects were be capable of running a mile in less 
than 6 minutes and had a total weekly running volume 30 miles or more.  
Recreationally trained (n = 11) – These subjects were active most days of the week and 
not following an organized, periodized, resistance training program or aerobic program. Subjects 
were not able to run a mile in less than 6 minutes and squatted less than 1.5x bodyweight.  
Sedentary (n = 6) – These subjects had not taken part in any exercise program or sports 
for at least two years prior to the study. They were not active for more than 2 hours per week of 
exercise.  
Testing Preparation 
Subjects participated in several exercise tests to predict MHC characteristics. Subjects 
were instructed not to train the day directly prior to each testing session. If a subject did train the 
day before testing, their testing was to be rescheduled so there would be no fatigue pre-training 
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to negatively affect performance.  If subjects had an acute illness on the day of testing subjects 
were rescheduled at the next earliest opportunity for their session once they had recovered. 
Testing Schedule 
Subjects signed consent forms, a health history, and a training history questionnaire 
before taking part in anthropometric testing and familiarization. The subjects then scheduled 
their next testing day. During the next testing session, subjects performed the vertical jump test 
and dynamic constant external resistance (DCER) isotonic leg extension 1RM test. Subjects then 
returned 3-9 days later and performed a leg extension power load test, and modified Kansas 
squat power test on the leg extension. After completion of the tests, a muscle biopsy was 
performed. 
Subjects were instructed to come in at the same time each testing day. The time of day 
has been shown previously to have an effect on muscle activation and performance, as one study 
noted an effect on the elbow flexors (Gauthier, Davenne, Martin, Cometti, & Hoecke, 1996). The 
same effect was seen using a leg extension MVC test (Guette, Gondin, & Martin, 2005) and a 
Wingate power test (Chtourou et al., 2011). There is also a component of trainability  of which 
this peak performance occurs during the time of day (Souissi, Gauthier, Sesboüé, Larue, & 
Davenne, 2002). This adaptation seems to be mostly through peripheral mechanisms, not 
neurological (Sedliak, Finni, Peltonen, & Häkkinen, 2008). To control for this, subjects started 
each session of testing within a one hour window of the time they tested during their first 
session. 
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Figure 6 Timeline of subject testing for the visits in the study 
 
Body Composition and Anthropometrics 
A Dual-energy X-ray absorptiometry (DEXA) scanner was utilized to determine body fat 
percentage, as well as local and systemic lean body mass (Fuller, Laskey, & Elia, 1992). 
Additionally, thigh circumference measurements and skinfold thicknesses were taken to estimate 
thigh cross sectional area using the methods of Housh et al. (Housh et al., 1995). Height was 
taken with subjects standing without shoes on against a tape measure that is mounted to the wall. 
Weight was taken utilizing a floor scale (Toledo industrial floor scale 2136 8140 Digital, Mettler 
Toledo Columbus, OH). 
Familiarization 
Subjects completed informed consent forms and health history questionnaires. Subjects 
were instructed to detail their training from the previous week as a means to help classify the 
appropriate category to place the subject based upon their training history. Any questions that 
researchers had with the subjects exercise program were addressed at this point. After this, 
subjects underwent a DEXA scan for body composition and then performed jump 
familiarization. 
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Subjects performed two practice jumps where they attempted to touch as high on the 
Vertec as possible. They then performed 2 jumps without the use of their arms and 2 depth jumps 
off of a 12” box. Each jump was given a minimum of a one minute rest period. 
Subjects were then moved to the DCER leg extension machine (Biodex) (Biodex Leg 
extension Humac System 3, Biodex Medical Systems, Shirley, NY).  The seat position along 
with thigh pad was outfitted appropriately for each subject’s size and recorded for uniformity 
across each of the subjects testing sessions. Subjects were seated appropriately on the Biodex 
chair allowing for approximately one inch of clearance between the posterior portion of their 
lower leg and the bottom of the Biodex seat. Subjects were restrained by a waist strap, thigh 
strap, and shoulder straps to minimize any body movements. Subjects then grasped the handles at 
the sides of the chair for each trial throughout all of the tests in the study.  
Subjects performed 3 sets of slightly increasing resistance. Loads for these sets were 5 
repetitions at 10lbs. of resistance, 20lbs. of resistance, and 40lbs. of resistance. At this point 
subjects were then built up to an attempted 1RM based upon performance of previous 
repetitions, with no larger than a 20lb. increase. They performed a familiarization of the 
fatiguing protocol of 5 repetitions at 70% of the highest load attained. Rest periods between each 
of these sets were at least one minute.  At this point subjects were finished with their 
familiarization and were scheduled for their following visit. 
Vertical jump performance 
Subjects warmed up for 5 minute ride on a stationary bicycle at a self-selected cadence 
and resistance. Afterwards, they performed 2 maximal, vertical jumps utilizing an arm 
countermovement swing on a force plate. Following this, subjects performed 2 maximal, vertical 
jumps with their hands on their waist. Finally, subjects performed 2 maximal depth jumps from a 
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12” box. For the depth jump the subjects were instructed to step off the box so that they would 
drop from the height for the rebound. This was to avoid any variability in jumps off the box or 
stepping down and losing the effect on the vertical jump. Between each jump, subjects were 
given a one minute rest period before the following jump. Jumps were performed on a force plate 
(Rough Deck, Rice Lake) to allow for force production and flight time to be recorded. Force 
plate data was interfaced with a Biopac MP150 voltage interface (Biopac Systems Inc, Goleta, 
CA) and visual displayed and signals recorded with AcqKnowledge software (version 3 Biopac 
Systems Inc.) at a sampling frequency of 2000 Hz. Signals were filtered utilizing a Butterworth 
low-pass filter with cut off frequencies of 10Hz. Jump height, power, rate of force development, 
and impulse was later derived utilizing Biopac interfaced AcqKnowledge software. A Vertec 
(Power Systems Inc. Knoxville, TN) was utilized to give the subjects a visual objective to jump 
and touch on the countermovement jump. Standing reach was recorded and utilized to measure 
the highest jump and touch achieved. Standing reach was measured by both hands overlapping at 
the middle finger when reached as far above the head as possible on flat feet, measured to the 
nearest half inch. Peak and mean power performance was estimated utilizing the Harman 
equations (Harman 1991). Force plate was calibrated daily utilizing a load of 300kg. 
Vertical jumps were analyzed for rate of force development, which was defined as the 
amount of time which passed between the point when force was equivalent to the body weight of 
the subject until the peak force was attained. Impulse was calculated as the sum of the average 
force during concentric portion of the jumping movement multiplied by the ground contact time. 
Lastly, peak and mean power for vertical jump performance were calculated utilizing the 
Harman equation for each of the different jumps (Harman, Rosenstein, Frykman, Rosenstein, & 
Kraemer, 1991). 
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Maximal isotonic leg extensions 
Subjects were tested on the Biodex machine for a right leg extension for their 1RM. Each 
repetition was measured utilizing national instruments CDAQ-9174 with NI 9215 ports (National 
Instruments Corporation, Austin, TX) receiving signals directly from the Biodex Humac System 
3 unit (Biodex inc.). Each sets was performed on the isotonic testing mode in with the Humac 
Software (2009v 10.000.0047, Biodex Inc.). Signals were recorded with researcher created 
custom programs with Labview software (NI Labview 2013, National Instruments Corporation), 
which recorded torque, velocity, direction, and position sampled at a frequency of 1000Hz. Data 
was conditioned with Butterworth 10Hz cut off frequencies. All data was analyzed utilizing 
Microsoft Excel software for performance. The start of each repetition was defined as the point 
of which rotational velocity exceeded one degree per second, end of repetition was defined as the 
point of which the direction signal voltage changed to negative direction. Subjects warmed up 
with a set of 5 repetitions at 10lbs, 3 repetitions at 20lbs. and 2 repetitions at 40lbs. Following 
the warm-up, the subjects started perform single attempts at 50lbs-60lbs. Each set, the load was 
increased by 5-20lbs. depending on the subject’s familiarization 1RM and the rated exertion on 
the previous set. There was a 60-90 second rest period between sets. Once the subject attained 
their 1RM they were done with their participation for the day and the final testing session was 
scheduled. Range of motion calibration data was saved from each subject and calibration of 
torque and velocity signals were performed weekly to show consistence of values which 
correlated at r = 1.0 (P <.001). 
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Leg extension power testing 
For the final testing session, subjects performed 5 minutes of riding on the stationary bike 
at a self-selected cadence and resistance. After the warm up, subjects performed maximal 
velocity repetitions at 30%, 40%, 50%, 60%, 70%, 80%, and 90% of their 1 RM. Loads were set 
to the nearest tenth of a pound of resistance. Each set consisted of two maximal velocity 
repetitions. Each repetition was separated by a three second pause. Torque, direction, position, 
and velocity were recorded for each repetition (Schilling, Fry, Weiss, et al., 2005). Subjects were 
given two minute rest periods between each set. Greatest rep by peak velocity was utilized for 
later analysis from each different percentage load. 
Following this test the fatiguing protocol was performed, subjects performed 15 
repetitions at 70% of their 1RM with 3 second rest intervals for each rep. Cadence was 
maintained by researcher providing a verbal and visual signal. Subjects were instructed give their 
best effort on each repetition (Fry et al., 2013). Adjustments for limb weight and size were not 
made (Winter, Wells, & Orr, 1981). At the end of this test, the muscle biopsy on the subject’s 
vastus lateralis was performed. 
Muscle Biopsy 
Muscle biopsies were taken from the vastus lateralis on the midpoint of the thigh, 
midway between the inguinal ligament and the patella on the right leg after the fatiguing 
protocol. Subjects were instructed to lie on the biopsy table face up. The area where the muscle 
biopsy was performed was cleaned with betadine and shaved to decrease infection risk and 
possible scaring. Subjects then had lidocaine injected to numb the area. After 5-10 minutes had 
elapsed, subjects were then tested to ensure that the lidocaine had taken effect. If it had not, 
subjects were either given more time, more lidocaine, or both. Once a subject was numb, a sterile 
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scalpel was used to make an approximately 1 cm incision that was roughly 2.5 cm deep. A 
Bergstrom biopsy needle was then inserted, utilizing the double chop method and suction utilized 
by Staron et al. (Staron et al., 1990) and a muscle sample was taken. Samples were then mounted 
on traganth gum and frozen with isopentane for later analysis of MHC characteristics.   
The subject’s leg area was then cleaned with isopropyl alcohol around the area of the 
biopsy, but not directly in the incision site. Skin adhesive was applied directly above and below 
the incision and steri strips were used to close the wound. A sterile bandage was then placed over 
the incision site and cotton gauze and a pressure wrap bandage were placed over the bandage, to 
help keep the area clean of any possible debris. The leg was then bound with flex wrap. Subjects 
were instructed to keep the incision dry and clean and to return in 24 hours so that the wound 
area could be examined and re-bandaged.  They were given contact information of the staff in 
case a situation occurred with the incision and they needed medical guidance. No such situations 
occurred with any of the subjects. 
Myosin Heavy Chain Analysis 
Sample Extraction 
Muscle samples were extracted utilizing a cryostat (MC1800 by Leica Inc.) taking 8-12 
40um serial cross sections into one microcentrifuge tube. Tubes were then put in solution with 
500ul of a lab recipe extraction buffer (A. C. Fry, 2004) (100ml total of 62.5mm Tris HCl 
(Fisher Scientific), 5 ml beta-mercaptoethanol (Pierce Scientific), 2.3g SDS (Fisher), glycerol 
(National Diagnostics) and were heated for 10 minutes at 60˚C. Samples were then vortexed and 
three drops of glycerol were added (National Diagnostics). Afterwards, samples were stored in a 
-80˚C freezer for later analysis. 
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Myosin Heavy Chain Separating 
Samples were run through a large format 4-8% gradient gel (using a Gradient Maker by 
Hoefer Inc.) utilizing a lab recipe for gels made of (protogel (National Diagnostics), ultra-pure 
DI water, glycerol, 1.5M Tris (Aldrich Scientific)) stacking gel of 4% (.5M Tris). Fresh running 
buffer was made daily with a lab recipe (glycine (Fisher), Tris, SDS) and approximately 5 liters 
will be utilized each time. Running buffer was pH controlled at 8.8 for each run at room 
temperature. After samples were loaded, the gels were run at a constant voltage of 120V for 18-
24 hours (Thermo Scientific EC250-90 power source), with a constant water cooling system 
maintaining case temperature at 19˚C (Fisher Isotemp 3016). After the leading edge of the gel 
had run off the bottom of the gel, the run was stopped and the gel was extracted to be washed in 
a commassie brilliant blue staining solution (methanol (Sigma Aldrich), glacial acetic acid 
(Fisher), ultra-pure Di water, commassie brilliant blue R (ICN Biomedical)) for half an hour to 
forty five minutes.  Then it was washed in a lab recipe stripping buffer (water, methanol, glacial 
acetic acid) for at least one hour. Gels were imaged utilizing a protein simple laboratory camera 
system (model U4000, firmware 27 by Alta Inc.).  The bands on each gel were analyzed utilizing 
Fluorchem 2 software (Protein Simple alpha view Fluorchem 2 version 3.4.0.0). All bands were 
analyzed at least three times for reliability between the analyses. 
Data analysis 
Demographic data for the subjects was analyzed utilizing a simple ANOVA, if there was 
a significant difference amongst the groups; post hoc analyses would utilize Bonferroni 
corrections. One-way ANOVAs were utilized to compare MHC composition among groups. 
Subject data was analyzed to compare muscle MHC characteristics to performance measures that 
were obtained.  
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Task Variable Variable Variable Variable 
Leg Extension Power Curve Linear velocity 
slope 
Linear velocity 
intercept 
Fatigue Index 
Vertical Jump Force Rate of force 
development 
Jump height Impulse 
Anthropometrics Body weight Body fat Thigh 
circumference 
Thigh mass 
MHC Type I Type IIA Type IIX  
Figure 7 Variables recorded from the study to be utilized for correlation to one another 
A correlation matrix of the above variables was performed for each variable to find where 
high covariance naturally occurs as a means to remove any unnecessary, extra variables. Vertical 
jump data was also analyzed relative to cross sectional area and to lean body mass for power and 
force measurements. After significant variables (alpha set at .05) were identified utilizing a 
correlation matrix with the heavy chain characteristics, significant correlation variables were 
then analyzed utilizing a regression or if there were multiple significant relationships data was 
analyzed utilizing a forward stepwise multiple regression.  
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Chapter 4 - Results 
This dissertation analyzed plyometric and isotonic performance and its relationship to 
muscle MHC composition. Each of the hypotheses proposed were answered utilizing the 
methodology outlined in chapter 3 and the results of each portion of the experiment were 
statistically analyzed from the quantified data and are reviewed below. 
Subject Attrition  
Of 46 subjects who enrolled initially in the study, 42 completed the study. The subjects 
who failed to complete the study were unable to do so due to personal reasons or inability to 
match schedules, not contraindications from testing. 
Demographics 
Averages below are representative of subject participants, divided by sample group 
(Table 1, 2): 
Table 1 – Demographics - All units are mean ± standard deviation 
  
Group N Age (years) Height (m) Weight (kg) Body Fat (%) 
Aerobic 12 22.5±2.9 1.79±.08 70.1±5.7 10.9±4.1 
Resistance  13 22.0±1.8 1.75±.04 80.8±11.5 14.7±5.9 
Recreational 11 22.0±2.6 1.81±.08 84.2±17 17.3±7.0 
Sedentary 6 24.0±7.6 1.81±.09 81.2±14.7 23.2±6.2* 
Total 42 22.4±3.5 1.78±.07 78.7±13.3 15.5±6.9 
 * denotes significance of p < .05 
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Table 2 - Leg Size Information - All units are mean ± standard deviation 
 
Group Lean Mass 
(kg) 
Lean Mass Right 
Leg (kg) 
Quad CSA (cm
2
) Thigh CSA (cm
2
) 
Aerobic 58.7±5.0 9.7±.8 73.4±8.2 141.3±14.9 
Resistance  65.1±7.0 10.9±1.4 86.2±8.6* 165.9±16.4* 
Recreational 64.8±9.3 10.7±1.4 81.5±10.1 157.7±19.0 
Sedentary 57.9±7.2 10.0±1.7 67.0±12.2 131.6±21.4 
Total 62.2±7.7 10.4±1.4 78.6±11.5 151.8±21.4 
* denotes significance of p < .05 
 
In general, there were only significant differences between groups with body fat 
percentage (p = .001), and quad and thigh cross sectional area (CSA) (p = .001, and p = .001 
respectively). The sedentary group had statistically significantly greater amounts of body fat than 
the other groups, whereas the resistance trained group had significantly larger quad and thigh 
size than the other groups (utilizing Bonferroni corrections for post hoc tests). 
Leg Extension Maximum – 
Table 3 - Maximum Leg Extension - All units are mean ± standard dev. 
Group Maximum Leg Extension (kg) Max Leg Extension Relative to CSA 
Aerobic 31.5±6.5 .94±.15 
Resistance  36.5±7.3 .93±.15 
Recreational 37.4±10.2 1.00±.21 
Sedentary 29.9±4.2 .99±.13 
Total 34.4±8.0 .96±.16 
There was no significant difference seen in leg extension strength between each of the 
groups or when controlled for cross sectional area (Table 3). 
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Muscle Myosin Heavy Chain –  
Table 4 - Myosin Heavy Chain data for all of the subjects across groups and total - All 
units are mean ± standard dev. 
Group IIX (%) IIA (%) I (%) Total Fast Twitch (%) 
Aerobic 10.3±7.1 47.3±8.8 42.2±9.9 59.4±10.8 
Resistance  9.9±9.8 54.9±9.1 35.4±9.1 64.8±9.0 
Recreational 14.0±13.3 49.9±11.2 36.4±13.1 62.0±13.5 
Sedentary 31.1±17.1* 39.5±11.6 29.4±12.2 70.6±10.9 
Total 13.8±12.9 49.5±10.3 36.8±11.3 63.3±11.3 
* denotes significance of p < .05 
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Figure 8 IIX MHC content across subject groups 
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Figure 9 IIA MHC content across subject groups 
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Figure 10 I MHC content across subject groups 
No significant differences were found in the type IIA or I muscle MHC between any of 
the groups. There were significant differences in IIX MHC between groups (Table 4) (Figure 8, 
9, 10).  A post hoc analysis utilizing Bonferroni corrections, found that the sedentary group had a 
significantly greater amount of IIX fiber than any other group (p> .05). 
Correlations of muscle MHC composition to one another results were as follows:  
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Table 5 - Correlations between each MHC Isoform 
MHC IIX IIA I 
IIX 1 -0.545* -0.646* 
IIA 
 
1 -0.285 
I     1 
* denotes significance of p < .05 
 
Hypothesis 1 
Vertical jump impulse, rate of force development, jump height, and power will have a 
positive relationship to vastus lateralis muscle fast MHC composition (IIA and IIX separately as 
well), specifically when variables are calculated relative to body mass and cross sectional area of 
the muscle.  
Jump Height 
Subjects performed each variation of the jump in the study. Most subjects performed two 
maximal repetitions of each jump. For statistical purposes, maximum height jump data was used 
for statistical analysis. Vertical jump performance data is listed in table 6. 
Table 6 - Jump Height Performance - All units are mean ± standard dev. 
Group CM Jump (m) No arm Jump (m) Depth Jump (m) 
Aerobic 0.699±.036* 0.659±.037* 0.703±.031 
Resistance  0.746±.046
+
 0.705±.042
+
 0.748±.045 
Recreational 0.713±.040 0.677±.038 0.717±.044 
Sedentary 0.681±.050 0.633±.027 0.678±.053 
Total 0.715±.047 0.674±.044 0.717±.047 
* denotes significant below group average  
+ Denotes significant above group average ( p < .05) 
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Table 7- MHC Correlation to Jump Height Performance 
 
Vertical Jump Height 
 
Counter movement No Arms Depth Jump 
MHC r p r p r p 
IIX 0.238 0.129 0.111 0.486 0.164 0.299 
IIA 0.089 0.574 0.129 0.415 0.021 0.895 
I -0.355* 0.021 -0.249 0.111 -0.209 0.184 
* denotes significance of p < .05 
 
Figure 11 - Scatterplot for Type I MHC correlation to Countermovement Jump Height 
A one way ANOVA showed significant differences in vertical jump height between each 
of the testing groups. With Bonferroni post hoc analysis, the aerobically trained group performed 
significantly below average in the counter movement jump and no arm jump, whereas the 
resistance trained group performed above average (p<.05). There was a significant negative 
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relationship between vertical jump height (only counter movement jump trial) and type I fiber 
concentration (r = -.355, p = .021) (Table 7)(Figure 11). 
Force 
 Force produced during the jumping phase was calculated through the point of which 
force on the concentric portion of the jump was equal to body weight. Peak and mean force on 
only the counter movement jump was significantly related to type IIX MHC composition (r= 
.354, p = .021 and r = .356, p = .021 respectively). There were no other significant relationships 
to force and MHC (Table 8, 9) (Figure 12, 13). 
Table 8 - Peak force relative to Body Weight (N/kg) 
  
 
Counter movement No Arms Depth Jump 
MHC r p r p r p 
IIX 0.354* 0.021 0.228 0.146 0.238 0.129 
IIA -0.258 0.099 -0.096 0.545 -0.153 0.333 
I -0.173 0.272 -0.167 0.289 -0.123 0.437 
* denotes significance of p < .05 
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Figure 12 - Scatterplot of MHC IIX correlation to Peak Force Relative to Body Weight 
Table 9 - Mean force relative to Body Weight (N/kg) 
 
 
 
Counter movement No Arms Depth Jump 
MHC r p r p r p 
IIX 0.356* 0.021 0.144 0.361 0.129 0.414 
IIA -0.177 0.261 0.072 0.651 0.021 0.897 
I -0.241 0.124 -0.209 0.183 -0.154 0.332 
* denotes significance of p < .05 
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Figure 13- 
Scatterplot of IIX MHC correlation to Mean Force Relative to Bodyweight 
Jump Power 
Results showed a significant, positive relationship for vertical jump power between IIX 
MHC across all jump types. Peak power in each of the jumps relative to cross sectional area of 
the thigh had significant relationships (counter movement jump r = .449 p=.003, no arm jump r = 
.429 p=.005, depth jump r = .437 p=.004). The same results were seen in mean power in each of 
the jump trials relative to cross sectional area of the thigh (counter movement jump r = .483 p = 
.001, no arm jump r = .434 p = .004, depth jump r = .459 p = .002) (Table 10, 11). 
There were significant negative relationships between IIA MHC composition and power 
performance. Peak power in each of the jumps to cross sectional area of the thigh had significant 
relationships (counter movement jump r = -.411 p=007, no arm jump r = -.407 p=008, depth 
jump r = -.422 p=005). The same results were seen with mean power in each of the jumps 
relative to cross sectional area of the thigh (counter movement jump r = -.341 p = .027, no arm 
jump r = -.318 p = .040, depth jump r = -.373 p = .015) (Table 10, 11) (Figure 14, 15, 16, 17, 18, 
19, 20, 21, 22, 23, 24, 25). 
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No significant relationship was seen between type I fiber and vertical jump performance 
across any of the force or power metrics in any of the jumps (Table 8, 9, 10, 11). 
Table 10 – Correlation of peak power relative to cross sectional area of the thigh to MHC 
content 
 
 
Peak Power  
 
Counter Movement No Arms Depth Jump 
MHC r p r p r p 
IIX 0.446* 0.003 0.429* 0.005 0.437* 0.004 
IIA -0.411* 0.007 -0.407* 0.008 -0.422* 0.005 
I -0.143 0.368 -0.128 0.421 -0.122 0.441 
* denotes significance of p < .05 
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Figure 14 Scatterplot of IIX MHC content to Peak Power relative to cross sectional are in 
the countermovement jump 
 
Figure 15 Scatterplot of IIX MHC correlation to Peak Power relative to Cross Sectional 
Area No Arm Jump 
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Figure 16 Scatterplot IIX MHC correlation to Peak Power relative to Cross Sectional Area 
Depth Jump 
 
Figure 17- Scatterplot of IIA MHC correlation to Peak Power relative to Cross Sectional 
Area Counter Movement Jump 
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Figure 18 Scatterplot of IIA MHC correlation to Peak Power relative to Cross Sectional 
Area No Arm Jump 
 
Figure 19 Scatterplot of IIA MHC correlation to Peak Power relative to Cross Sectional 
Area Depth Jump 
Table 11 - Correlation of mean power relative to cross sectional area of the thigh to MHC 
content 
 
Mean Power  
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Counter Movement No Arms Depth Jump 
MHC r p r p r P 
IIX 0.483* 0.001 0.434* 0.004 0.459* 0.002 
IIA -0.341* 0.027 -0.308* 0.04 -0.373* 0.015 
I -0.247 0.115 -0.213 0.176 -0.191 0.227 
* denotes significance of p < .05 
 
Figure 20 Scatterplot of IIX MHC correlation to Mean Power relative to Cross Sectional 
Area Counter Movement Jump 
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Figure 21 Scatterplot of IIX MHC correlation to Mean Power relative to Cross Sectional 
Area No Arm Jump 
 
Figure 22 Scatterplot of IIX MHC correlation to Mean Power relative to Cross Sectional 
Area Depth Jump 
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Figure 23 Scatterplot of IIA MHC correlation to Mean Power relative to Cross Sectional 
Area  Counter Movement Jump 
 
Figure 24 Scatterplot of IIA MHC correlation to Mean Power relative to Cross Sectional 
Area No Arm Jump 
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Figure 25 Scatterplot of IIA MHC correlation to Mean Power relative to Cross Sectional 
Area Depth Jump 
Rate of Force of Development –  
No significant correlations were seen between rate of force development across any of 
the jump conditions and MHC, with the exception of a positive relationship between IIX fiber 
concentration and rate of force development relative to cross sectional area in the counter 
movement jump trial (r = .329, p = .033) (Table 12) (Figure 26).  
Table 12 - Rate of force development Relative to Cross Sectional Area correlation to MHC 
 
 
Counter movement No Arms Depth Jump 
MHC r p r p r p 
IIX 0.329* 0.033 0.119 0.454 0.1 0.53 
IIA -0.205 0.192 0.087 0.584 -0.242 0.123 
I -0.192 0.224 -0.199 0.206 0.104 0.512 
* denotes significance of p < .05 
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Figure 26 Scatterplot of IIX MHC correlation to Rate of Force Development relative to 
Cross Sectional Area 
Impulse  
No significant correlations were seen between impulse and MHC across any of the jump 
conditions. Impulse (N*sec.) for the counter movement jump was 1829.4 ± 917.4, no arm jump 
was 1599.7 ± 911.5, and the depth jump was 3073.5 ± 2386.6. 
Hypothesis 2 
Isotonic leg extension velocity-load linear relationship will be related to muscle MHC 
with fast fiber (specifically IIA) positively and negatively correlated, respectively, to the 
intercept of the line and the slope of the line. 
Velocity Load 
After leg extension data was broken down by individual repetitions, the best repetition of 
each percentage set was utilized to create a linear equation for leg extension velocity 
performance at each percentage of their individual 1RM. Figure 27 displays one of the subjects 
graphs (Figure 27). The average intercept for peak velocity was 415.1 deg/sec ± 47.7 with a 
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y = -0.6644x + 201.15 
R² = 0.9047 
y = -1.4284x + 379.96 
R² = 0.9828 
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slope of -2.13 ± .50 deg/sec by increase in percentage of max. Mean intercept for average 
velocity 217.7 ± 16.2 deg/sec with a slope of -1.03 ± .26 deg/sec by increase in percentage of 
max (Table 13). There were no significant differences between of the groups. 
Table 13 - Velocity load best fit lines - All units are mean ± standard dev. 
Velocity Load Best 
Fit Lines 
Slope ((deg/sec)/percentage of 
1RM) 
Intercept ((deg/sec)/percentage 
of 1RM) 
Group Max Velocity  Mean 
Velocity 
Max Velocity  Mean 
Velocity 
Aerobic -2.022±.348 -1.037±.270 397.49±32.97 214.01±15.53 
Resistance  -2.251±.628 -1.042±.321 436.06±50.16 222.32±13.89 
Recreational -2.154±.587 -1.017±.195 411.29±58.82 214.64±16.97 
Sedentary -2.026±.250 -0.9934±.291 411.67±37.10 220.36±21.81 
Total -2.128±.499 -1.027±.264 415.07±47.70 217.65±16.24 
 
 
 
 
 
 
 
 
 
Figure 27 - Velocity Load relationship graph for one of the subjects in 
the study 
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 Intercept  
The estimated velocity attainable in an unloaded condition for the muscle was estimated utilizing 
linear regression for both peak and mean velocity data. Intercepts were correlated with MHC 
(Table 14) (Figure 28, 29); peak velocity intercept related to IIA concentration r = .380 (f = 
6.752, p = .013, df = 1, 40) creating an intercept equation of:  
Intercept = 1.759 (percent IIA) + 327.950 (deg./sec) 
Equation 1 - Peak Velocity Intercept to MHC 
Mean velocity intercept related to IIA concentration r = .410 (f = 8.106, p = .007, df = 1, 
40) creating an intercept equation of:  
Intercept = .647 (percent IIA) + 185.611 (deg./sec) 
Equation 2 - Mean Velocity Intercept to MHC 
Table 14 Velocity Load Intercept correlation to MHC 
 
Peak Intercept Mean Intercept 
MHC r p r p 
IIX -0.228 0.147 -0.209 0.185 
IIA 0.380* 0.013 0.410* 0.007 
I -0.085 0.592 -0.141 0.373 
* denotes significance of p < .05 
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Figure 28 Scatterplot of IIA MHC correlation to Peak Velocity Intercept 
 
Figure 29 Scatterplot of IIA MHC correlation to Mean Velocity Intercept 
Slope  
The slope of best fit regression line for velocity attained along the differing percentage of 
the subject’s 1 RM for the leg extension was compared to determine a relationship with type IIA 
and IIX fibers. A relationship was seen between the peak and mean velocity slopes and IIA fiber 
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concentration (r = -.480 p = .001, and r=-.377 p=.014, respectively). No other significant 
relationships were seen between other MHC and slope (Table 15) (Figure 30, 31).  
Table 15 - Velocity load slope correlation to MHC 
 
Peak Slope Mean slope 
MHC r p r p 
IIX 0.221 0.159 0.183 0.247 
IIA -0.480* 0.001 -0.377* 0.014 
I 0.185 0.242 0.143 0.367 
* denotes significance of p < .05 
 
Figure 30 Scatterplot for IIA MHC correlation to Peak Velocity Slope 
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Figure 31 Scatterplot for IIA MHC correlation to Mean Velocity Slope 
Significant relationships were seen with slope and peak velocity (f=11.951, p=.001, df = 
1, 40) with an r = -.480:  
Slope equation = -.023 (percent IIA) -.977 
Equation 3 - Peak Velocity Slope to MHC equation 
The relationship of the slope to mean velocity was significant r=.377 (f=6.607, p=.014 df 
1, 40) with an equation of:  
Predicted slope = -.01 (percent IIA) -.550). 
Equation 4 - Mean Velocity Slope to MHC equation 
Hypothesis 3 
Isotonic leg extension power-load curves will be related to % MHC IIA, specifically the 
point of which the peak occurs at; earlier peaks relative to percentage of the total load will be 
negatively related to fast fiber composition. 
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
0 10 20 30 40 50 60
M
e
an
 V
e
lo
ci
ty
 S
lo
p
e
 
Type IIA (Percentage) 
80 
 
After participation in speed trials, peak and mean power performance for each repetition 
was calculated, and a best fit, 2
nd
 order polynomial line was created with an intercept of 0. Slope 
equations for these lines were then solved for each subject based upon where the anticipated 
peak performance for both power measures would occur as a percentage of 1 RM (Figure 32).  
Results for each group and subjects are listed in (Table 16) (Figure 33, 34, 35). Values were then 
compared to the MHC composition for each subject. There were no differences between groups 
with predicted power values. 
Table 16 - Predicted max power percentage - All units are mean ± standard dev. 
Predicted Peak  
Group Max Power (%) Mean Power (%) 
Aerobic 62.0±3.6 61.7±5.6 
Resistance  62.6±6.0 62.0±4.1 
Recreational 62.8±4.7 61.4±3.1 
Sedentary 61.7±2.0 60.2±2.8 
Total 62.5±4.5 61.5±4.1 
Peak Power 
A weak relationship (p= .034, f = 4.830, df = 1, 40) between peak power and IIA fiber 
was seen, but no significant relationship to type IIX or I fiber (r = -.328) (Table 17). The 
relationship between predicted maximal power percentage and IIA MHC composition is:   
Percent max power occurs = -.142 (percent IIA) + 69.410. 
Equation 5 - Percent Max Power Occurs (Peak Power) 
Mean Power 
Mean power was also weakly related to IIA and I fiber, but not to type IIX (r = -.352 p= .022 and 
r = .314, p = .043, respectively) (Table 17). The relationship between predicted mean power 
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maximum percentage and IIA and I MHC composition is (r = .417, f = 4.103, p = .024, df = 2, 
39):  
Percent max power occurs = -.114 (percent IIA) + .085 (percent I) + 64.025 
Equation 6 - Percent Max Power Occurs (Mean Power) 
Table 17 Correlation of predicted power maximum to MHC 
 
Predicted Peak Power Predicted Mean Power 
MHC r p r p 
IIX 0.034 0.83 0.011 0.946 
IIA -0.328* 0.034 -0.352* 0.022 
I 0.26 0.097 0.314* 0.043 
* denotes significance of p < .05 
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Figure 32 - Power load curve generated for one of the subjects in the study
 
Figure 33 Scatterplot for IIA MHC correlation to Predicted Peak Power Maximum 
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Figure 34 Scatterplot for IIA MHC correlation to Predicted Mean Power Maximum 
 
Figure 35 Scatterplot for I MHC correlation to Predicted Mean Power Maximum 
Hypothesis 4 
 Isotonic leg extension power test fatigue index will be positively related to total 
concentration of the combination of both fast isoforms. 
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Each subject completed the fatiguing protocol for 15 repetitions with a full range of 
motion (Figure 36). Data was analyzed for the highest performance of each variable and a fatigue 
index was derived by comparing highest and lowest performance in the repetitions after the peak 
performance.  
Fatigue index formula= ((highest rep – lowest rep)/highest rep) x 100.    
 
 
Figure 36 Velocity fatigue graph performance for one of the subjects in the study 
 
 
 
 
 
 
85 
 
 Fatigue indexes were computed for both mean and maximal velocity, torque, and power.  
Table 18 - Fatigue index values - All units are mean ± standard deviation (all measurements 
are in percent decline) 
 
Results are as follows (Table 18): 
One way analysis of the fatigue protocol showed no significant differences in fatigue 
between groups. 
 Fatigue Index  
Group Mean 
Velocity  
Mean 
Torque 
Mean 
Power 
Maximal 
Velocity 
Maximal 
Torque 
Maximal 
Power 
Aerobic 23.0±10.0 16.2±6.9 30.1±10.4 21.1±7.6 11.0±4.0 28.4±10.4 
Resistance  23.7±10.0 13.7±5.5 30.3±9.5 20.7±9.4 12.4±4.5 27.8±9.4 
Recreational 24.6±5.3 13.1±7.4 30.1±4.4 25.1±7.6 13.5±3.3 32.3±7.7 
Sedentary 24.3±9.4 16.9±4.9 33.1±7.6 23.5±6.7 15.2±4.8 31.7±6.3 
Total 23.8±8.6 14.7±6.3 30.6±8.3 22.4±8.0 12.7±4.2 29.7±8.9 
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Table 19 - Fatigue index correlation to MHC 
 
Mean Velocity Mean Torque Mean Power Peak Velocity Peak Torque Peak Power 
MHC r p r p r p r p r p r p 
IIX -0.006 0.968 0.283 0.069 0.074 0.642 -0.013 0.932 0.043 0.786 0.02 0.899 
IIA 0.319* 0.039 -0.269 0.085 0.237 0.13 0.298 0.055 0.464* 0.002 0.292 0.061 
I -0.277 0.075 -0.072 0.651 -0.292 0.061 -0.255 0.103 -0.473* 0.002 -0.29 0.062 
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Figure 37 Scatterplot for IIA MHC correlation to Fatigue Index Mean Velocity 
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Figure 38 Scatterplot for IIA MHC correlation to Fatigue Index Peak Torque 
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Figure 39 Scatterplot for I MHC correlation to Fatigue Index Peak Torque
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Fatigue index scores were correlated with total fast fiber content and the only significant 
relationship was found to be with maximal torque. This relationship had a relationship of r = -
.474 (p = .002). Fatigue index scores were then analyzed based upon each MHC and 
relationships were found as follows (Table 19) (Figure 37, 38, 39). 
Velocity   
Velocity fatigue index showed a relationship to IIA MHC concentration and mean 
velocity fatigue index values of r = -.319 p=.039 (f = 4.54, df 1, 40) (Table 19). There was no 
relationship of any other MHC to velocity fatigue index for the other mean maximal values. The 
predicted regression equation for velocity fatigue drop off to IIA MHC was:  
Mean Velocity Fatigue Index = -.268 (percent IIA) – 10.549. 
Equation 7 - Mean Velocity Fatigue Index MHC relationship 
Power  
          No significant relationship between peak power or mean power fatigue index was 
observed with any MHC isoform (Table 19). 
Torque  
There was a significant relationship between maximum torque fatigue index values and 
both IIA (r = -.464, p=.002) and type I fiber (r = .473 p =.002) content (Table 19). When entered 
into a step-wise linear regression with IIA fibers, followed by type I fibers, resultant 
relationships were as follows: r = .586 (f=10.118, p < .001, df = 2, 39) with a prediction equation 
of:  
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Maximum Torque Fatigue Index = .137 (percent I) - .146 (percent IIA) – 10.508 
Equation 8 – Maximum Torque Fatigue Index MHC relationship 
 
Stepwise Linear Regressions for Myosin Heavy Chain 
 Stepwise linear regressions were performed to find the strongest statistical prediction 
possible for each of the MHCs based upon the strongest correlating variable from each of the 4 
hypotheses. The variables chosen and the results seen for each are as follows. 
Type IIX Fiber - The stepwise linear regression for IIX fiber best fit followed the order 
of rate of force development relative to cross sectional area in the vertical jump, mean power 
relative to cross sectional area on the vertical jump, and peak velocity intercept.  This model 
ended with an r = .544, f = 5.318 p = .004 with df = 3, 38. The final regression equation was:  
IIX Percent = 225.527 (mean power relative to cross sectional area of the thigh in the 
vertical jump) + .126 (rate of force development relative to cross sectional area in the vertical 
jump) - .010 (peak velocity intercept) – 23.846. 
Type IIA Fiber– The stepwise linear regression for IIA fiber best fit followed the order 
of peak velocity slope and intercept, percent mean power maximum predicted, fatigue index for 
maximum torque, and peak power relative to cross sectional area on the depth jump. This model 
ended with an r = .679, f = 6.153 p < .001 with df = 5, 36. The final regression equation was:  
IIA percent = 7.655 (peak velocity slope) - .035 (peak velocity intercept) + .079 (percent 
mean power maximum predicted) - .967 (fatigue index for maximum torque) – 21.734 (peak 
power relative to cross sectional area on the depth jump) + 48.292. 
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Type I Fiber – The stepwise linear regression for type I fiber best fit followed the 
stepwise regression entry order of: maximum torque fatigue index, percent mean power 
maximum predicted, vertical jump height, and peak velocity slope. This model had an r = .597, f 
= 5.118, p = .002, df 4, 37. The final regression equation produced was:  
I percent = 1.231 (maximum torque fatigue index) + .334 (percent mean power maximum 
predicted), -87.317 (vertical jump height), 3.183 (peak velocity slope). 
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Chapter 5 - Discussion 
Through the multiple tests implemented in this dissertation, a variety of relationships 
were observed between MHC and performance. These relationships will be explored individually 
based upon the hypotheses covered. 
Subject Sample 
There was a large variability in MHC composition between the subjects in the study. The 
greater diversity in MHC expression in between the subject sample allowed for more 
relationships to be seen. Future research could find even higher level aerobic and resistance 
trained athletes for greater concentrations of type I and IIA respectively to help increase the fiber 
variability between subjects even further (Schilling, Fry, Weiss, & Chiu, 2005). The variability 
in IIX was very good, one indication being the significance in the concentration of the MHC in 
the sedentary group compared to the other groups.  
Our research is limited in that we only took one muscle biopsy for indication of muscle 
MHC which does vary along the length and depth of the muscle (Dahmane, Djordjevič, Šimunič, 
& Valenčič, 2005; Elder, Bradbury, & Roberts, 1982; Lexell, Henriksson‐Larsén, Winblad, & 
Sjöström, 1983). We did sample from the same biological landmark on each of the subjects, and 
the vast majority of MHC studies have been based off of a single muscle biopsy (Fry, 2002; Fry, 
Schilling, et al., 2003; Fry, Webber, et al., 2003). 
There was a significant relationship between IIX MHC and both IIA and I fiber in the 
form of a negative correlation. There was however, no significant relationship between IIA and 
type I fiber. This is a logical result since IIX is the most readily decreased MHC with training 
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and so would be found in high amounts in the sedentary, and be decreased in trained individuals 
no matter the training stimulus (Pette & Staron, 2001; Schilling et al., 2005). 
Vertical Jumps 
This study collaborated the finding of a relationship previously reported by Eckerson and 
Fry (Eckerson, 2005; Fry, 2002) regarding the relationship between jump performance and IIX 
fiber composition.  Previous research by Fry et al. utilizing a sample of weightlifters, observed a 
correlation between jump power and type II fiber characteristics. However, this study did not 
find the same relationship that resulted from our data, possibly due to a difference in training 
methods and techniques between power lifters and weight lifters, potentially affecting 
neurological recruitment properties of the muscle (Fry, Schilling, et al., 2003). We however, did 
not find a relationship with rate of force development and impulse, except for rate of force 
development in the counter movement jump trial when controlling for cross sectional area with 
IIX fiber. This is unlike the results from Eckerson and Fry, however, the sample size for this 
study was much greater (Eckerson, 2005; Fry, 2002). Further research in this area could have a 
greater amount of familiarization time with all of the jump varieties to allow for greater jumping 
efficiency with the subjects.  
By incorporating cross sectional area of the muscle mass significance was found in a 
number of variables to type IIX fiber proportion and jump performance. Since IIX fibers have 
ten times the power production of type I fibers and two times the power production of IIA fibers 
in single fiber studies (Bottinelli, Canepari, Pellegrino, & Reggiani, 1996; Bottinelli, Pellegrino, 
Canepari, Rossi, & Reggiani, 1999; Bottinelli, Schiaffino, & Reggiani, 1991; Widrick, Trappe, 
Costill, & Fitts, 1996) it makes sense that a muscle with a greater proportion would be able to 
create a greater amount of power relative in size. The negative relationship to type IIA MHC and 
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jump performance is of interest, since the resistance trained subjects and recreationally trained 
subjects had larger thigh girths when this extra size was accounted for this translated to a lower 
power production. This result has not been seen in any other research and should be investigated 
further to find if this result is consistent. In general utilizing cross sectional area testing should be 
incorporated in future field tests for MHC as a means to making performances relative to muscle 
size. 
These results lead to possible future research which should examine the same type of 
sample groups, but utilizing a greater variety of jumps to better explore the relationships to MHC 
and performance. Furthermore research should test with performing series of jumps, this has 
previously been seen in research (Bosco, Tihanyi, Komi, Fekete, & Apor, 1982) to be related to 
muscle MHC when examining fatigue index and holding static positions in the bottom of the 
squat for longer periods of time. These relationships were only analyzed with fast to slow MHC 
differentiation not the individual analysis of both fast isoforms. Further research examining rate 
of force development and vertical jump performance could also utilize smaller time intervals at 
the initial production of force along the lines of the research done by Andersen, which showed a 
greater, short time frame production of force (Andersen & Aagaard, 2006). Perhaps an additional 
analysis of this data set with a different definition of rate of force development could be used to 
examine this relationship. 
Velocity Load 
Velocity load performance results confirmed the hypothesis that both the intercept and 
slope of the best fit line would be related to muscle MHC, specifically IIA fiber. This builds on 
the research performed by Schilling et al. where little to no relationship to type IIX (or type I) 
was seen, but by increasing the number of sets at different velocities this current study was able 
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to observe significant relationships, however, not to IIX MHC (Schilling et al., 2005). Though 
there is a significant positive relationship between IIA fiber and the height of the intercept and 
the steepness of the slope, it was not a strong enough relationship to create a predictive model for 
MHC based upon exercise performance (r=.346-.410). Further research in this area could expand 
upon the model by recruiting a wider variety of subjects (different training histories) to 
participate and utilize a greater number of attempts at a wider variety of percentages of the 1RM. 
The reasoning for this is some research with an unweighted apparatus have shown a relationship 
to fast fiber (greater power and acceleration), but did not distinguish the fast fiber into both 
isoforms for statistical analysis (Houston, Norman, & Froese, 1988). So, perhaps additional sets 
at 0%, 10%, and 20% could add information to the model. 
Ancillary analyses could also look at the relative differences in performance at individual 
percentages and their relationships to MHC when controlling for cross sectional area which has 
been shown to occur in previous research (Tihanyi, Apor, & Fekete, 1982). 
 These results also fall in line with the research done using isokinetic devices. They have 
observed greater amounts of torque being produced from individuals with greater amounts of fast 
fiber. Our research further compartmentalized this data into the two fast isoforms, which shows a 
greater contribution of the IIA fiber and no significant relationship with the IIX fiber 
composition (Aagaard & Andersen, 1998; Coyle, Costill, & Lesmes, 1979; Gregor, Edgerton, 
Perrine, Campion, & DeBus, 1979), where some research has shown a negative relationship 
between performance and IIX fiber (Jürimäe, Abernethy, Quigley, Blake, & McEniery, 1997). 
This corresponds with the torque ratio that was observed by Gür et al., who  saw a relationship 
between the decrease in peak torque as isokinetic speeds increased relating to fast fiber (Gür, 
Gransberg, Knutsson, & Larsson, 2003). There are however other studies which detected no 
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significant results when examining the same variables, but were looking at slow fiber 
relationships and utilized slower isokinetic speeds (Schantz, Randall-Fox, Hutchison, Tyden, & 
Åstrand, 1983). Though our testing was isotonic, there seems to be some relationship with other 
studies and different performances across a variety of performed speeds due to MHC. 
Power Load 
Mathematically predicted max power for both mean and peak power measures was 
related to IIA fiber. This relationship showed that individuals with greater amounts of IIA fiber 
hit peak power at a lower percentage of their 1RM compared with individuals with a lower 
amount of IIA fiber. This could be attributable to a number of facts. First, previous research has 
generally related greater power outputs in general (Suter, Herzog, Sokolosky, Wiley, & 
Macintosh, 1993; Tihanyi et al., 1982), and at lower percentages (Froese & Houston, 1985), or 
even unweighted lever arm performance to greater amounts of fast twitch fiber (Houston et al., 
1988).  Secondly, this could be related to differences in motor unit activation and control through 
the subjects, as well trained subjects with greater motor control and activation could simply 
produce greater amounts of force, regardless of the load on the apparatus compared with subjects 
who have greater amounts of type IIX and I fiber. However, post hoc analysis of predicted 
maximum power values by group showed no significant differences between each group. 
Our study found that the point of which peak power occurs is much higher (in deg/sec) 
than found with isokinetic testing in previous research (Coyle et al., 1979; Lorentzon, Johansson, 
SjÖstrÖm, Fagerlund, & Fugl-Meyer, 1988; Thorstensson, Grimby, & Karlsson, 1976), but this 
is also comparing greatly different testing modalities in resistance application. This would be 
attributable to the differences in how force is applied between isokinetic and isotonic testing. The 
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performance of force application during isokinetic testing allows for greater force to be produced 
without the velocity of the arm being able to increase unlike isotonic testing. 
This relationship was not strong enough to be predictive of MHC (r=.328-352), but it is 
significant, indicating that further research in this area should build on this testing model 
utilizing a greater number of testing trials and a wider variety of percentages of the 1RM to be 
tested.  With larger testing data, it could be possible that a predictive relationship can be found 
and utilized for future scientific investigations. 
Fatigue 
The fatiguing protocol showed a significant relationship to type IIA muscle fiber and 
mean velocity fatigue index and max torque (r = .319, .464 respectively) a relationship between 
type I muscle fiber and max torque fatigue index (r = -.473). These relationships, though 
significant, were not strong enough to be strong predictors of muscle MHC based upon exercise 
performance. 
Fatiguing protocols such as Wingates have successfully linked fast twitch fiber and 
exercise performance, but have not been able to  disseminate between the two different fast fiber 
isoforms (Bar-Or et al., 1980). Additionally, sprinting fatigue trials at longer distances had a 
negative relationship to fast MHC, whereas the antithesis was seen in short distance trials (Inbar, 
Kaiser, & Tesch, 1981). This research agrees with previous research that was done with 
isokinetic testing (Lorentzon et al., 1988; Suter et al., 1993; Thorstensson & Karlsson, 1976) in 
that the fatigue index is related to heavy chain fiber content. However, the relationship was not 
as strong as that seen in previous research. The successful previous protocols did utilize a greater 
number of repetitions and due to their isokinetic nature did not run the risk of having prematurely 
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induced concentric failure. However, not all high rep fatiguing protocols have found success 
with linking MHC and fatigue rates with higher rep isokinetic performances (Clarkson, Kroll, & 
Melchionda, 1982; Clarkson et al., 1982).  
The results of this study also show a relationship with isotonic fatiguing protocols 
whereas previous studies have shown such a result (Rodriguez, 2005). This type of testing 
protocol looked instead at reps to failure, which could have incorporated a greater amount of 
subject motivation to perform to their full capacities, whereas a fatiguing protocol with a fixed 
number of reps may have an advantage psychologically to maintaining maximal performance.  
Successful fatiguing protocols that utilize leg extension testing all have a greater number 
of repetitions that are performed in the task compared to the tests that are not as successful, 
however these higher repetition sets are isokinetic so subject concentric failure is unlikely 
compared to lower repetition test which have been isotonic (Rodriguez, 2005; Thorstensson & 
Karlsson, 1976). Another approach to strengthening this model would be to utilize a sample 
population with little to no type IIX fiber, such as highly trained aerobic athletes (mile times less 
than 5 minutes) and resistance trained athletes (over two times bodyweight squatters) (Fry, 
Schilling, et al., 2003; Fry, Webber, et al., 2003). Since there was no statistically significant link 
between this MHC and performance, it would stand to reason that utilizing a population of only 
well trained individuals would make this a stronger test for prediction. Further research could 
also possibly slightly increase the repetitions but would still want to maintain a protocol that 
would end with subject full performance of each repetition.  
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Stepwise Regression 
An exploratory analysis of taking the strongest relationships from each of the different 
tasks to the individual MHC isoforms was performed utilizing a stepwise multiple regression. 
This data analysis found the strongest relationship to the tests predicting IIA fiber explaining 
approximately one third of the variance. This is not meant to be an end all, but given the great 
deal of variables that can affect exercise performance (neurological, diurnal, biochemical, etc.) 
this does create a moderate amount of prediction. However, the ability to predict muscle MHC 
with a high degree of certainty from isotonic tasks performed in this dissertation was not 
discovered. 
Conclusions 
A number of relationships between muscle MHC and performance were seen in both the 
vertical jump and leg extension tasks. While these relationships were significant, they were not 
strong enough to fully be indicative of muscle MHC. However, relationships between jumping 
power, jump height, velocity load, power max estimate, and fatigue index were seen with MHC. 
This indicates a broad array of indicators of muscle MHC to exercise performance humans of 
varying degrees of velocity and power production. Future research in this area should aim to 
control for more possible confounding variables such as motivation, subject abstinence from 
training, and motor efficiency with tasks should improve the relationships observed to MHC.   
Each MHC had different relationships to exercise performance, and no test was able to 
find significant relationships to all of the MHCs simultaneously. Though all muscle fibers are 
utilized in different manners, typically maximal efforts should illicit the use of all fibers. This 
research shows that individuals not just differentiating between fast and slow MHC is important, 
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but differentiating between the two fast MHCs is important when looking for significant 
differences between MHC and performance.  
There were a number of limitations to this study, in that, like all research with human 
subjects, there is a great deal of variability from subject to subject in motor control efficiency 
when performing the movements and subject motivation. Due to the wide variety of training 
backgrounds from the subjects, motor disparities on a number of tasks was notable by visual 
observation of jumping mechanics. Subject motivation to give their best performance on each 
repetition for the tasks could also be a confounding variable where a subject could underperform 
compared to their potential for each of the tasks which would introduce more error in to the 
model (Enoka et al., 2003; Kidgell & Pearce, 2011). Muscle pennation angles, attachment, 
general anthropometrics, and diet were not controlled for and could be other sources for greater 
variability in performance. 
Practical Applications 
MHC content is related to exercise performance. The strength and types of relationships 
are dependent on the speed of muscle action and the amount of power produced. This study did 
not create a predictive model for MHC based up on task performance, but did show various 
relationships to performance. In general high power movements and lower loads performance are 
related to both fast fibers for greater performance and lower performance with higher amounts of 
type I fiber. Resistance exercises variability of velocity performance as loads reach higher 
percentages of 1RM is also related to fast fiber IIA concentration. 
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Implications for further research 
Directions for further research have been outline above. The large gain in this study is to 
compare performance on relative metrics may that be relative to cross sectional area, percentage 
of 1RM, or fatigue index. By removing any confounding effects on performance that can occur 
from simply being a large or small subject has a positive effect on resultant observation for MHC 
differences. Vertical jump research should incorporate a greater variety of jumps to establish 
other links. Research linking the velocity load and percent that maximal power output is 
estimated to occur would be more effective with an even larger and more diverse sample size 
than this study offered. The link between isotonic fatiguing protocols and muscle MHC must be 
further examined, but incorporation of means to measure drop in performance in velocity, power, 
and torque are important for establishing a MHC relationship to performance. A greater number 
of biopsies feasible not only from the vastus lateralis but other muscles of the quadriceps (and 
perhaps the other major muscle groups of the lower body for jump performance) could further 
increase the strength of such a predictive model, but would introduce a greater amount of subject 
discomfort and risks. 
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Appendices 
Appendix A: Informed Consent 
Myosin Heavy Chain Characteristics and Exercise Performance. 
  
INTRODUCTION 
 
The Department of Health Sport and Exercise Sciences at the University of Kansas supports the 
practice of protection for human subjects participating in research. The following information is 
provided for you to decide whether you wish to participate in the present study. You may refuse 
to sign this form and not participate in this study. You should be aware that even if you agree to 
participate, you are free to withdraw at any time. If you do withdraw from this study, it will not 
affect your relationship with this unit, the services it may provide to you, or the University of 
Kansas. 
 
PURPOSE OF THE STUDY 
 
The primary purpose of this study is to examine the possible relationships between exercise 
performance and muscle fiber type composition (myosin heavy chain expression [MHC]). The 
secondary purpose of this study is to examine the differences in exercise performance based 
upon training history. 
 
PROCEDURES 
 
A time-line of the testing procedures and an overview of the testing sequence for the testing days 
are presented below.  All procedures will be conducted in the Neuromechanics Laboratory and 
the Applied Physiology Laboratory at the University of Kansas and will be supervised by trained 
personnel.  During the initial visit (visit 0) we will collect your baseline information (height, 
weight, etc.) and determine if you are eligible for this study.  Visit 1 will last approximately 1 
hour with visit 2 lasting approximately 1.5 hours. If you are eligible, visit 3 and 4 will take 
approximately 1 hour each. You will only be eligible for sessions 3 and 4 if have been resistance 
training for over one year and can estimate your barbell back squat. 
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Visit 0: Consent Form, pre-exercise testing health and exercise status questionnaire, 
determination of eligibility, demographics (height, weight, etc.), and familiarization with testing 
measurements. 
    
Visit 1 (day 0):  DEXA test 
Vertical jump test 
Leg extension maximal force test 
Leg extension isometric tracings 
 
Visit 2 (day 2-7): Kansas leg extension power test 
 Adapted Kansas squat power test 
 Vertical Jump 
 Muscle Biopsy 
 
Visit 3 (day 8-13) (only if eligible): Squat one repetition maximum test 
 
Visit 4 (day 14-20) (only if eligible): Kansas squat power curve test 
 Kansas squat power test 
 
DXA scan – This scan will require you to lie on a DXA machine while your body is scanned 
with a low level of x-rays (e.g. similar to flying in a commercial airplane) in order to determine 
your muscle mass, body composition, and bone mineral density. This scan will take 
approximately 7 minutes. 
 
Vertical jumps – You will be given a standardized warm up and then directly there after you will 
perform 3 maximal vertical jumps on a force plate reaching as high as you can on a vertec 
(vertical jump tester that you reach up and touch). You will be given a one minute rest period 
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between each jump. Then you will perform 3 maximal vertical jumps with your hands on your 
hips with the same rest periods. Finally you will perform 3 maximal jumps from a 21cm 
(approximately 9 inches) box. 
 
Leg Extension maximal force test - You will be positioned in the isokinetic dynamometer for leg 
extensor (thigh muscles) strength testing. After familiarization you will perform a standardized 
warm up on the biodex. Then the load will be increased in 5-10lbs. after each successful 
repetition until you are unable to complete a rep through a full range of motion. 
 
Isometric strength testing – You will be positioned in the isokinetic dynamometer for leg 
extensor (thigh muscles) strength testing.  After the positioning and prior to the strength tests, 
electromyographic (EMG) and mechanomyographic (MMG) electrodes will be placed on the 
skins surface of your right thigh.  You will then be instructed to contract your leg maximally for 
5 seconds in to the pad. You will then be given a minute rest period and repeat the process.  
 
Isometric tracing test – You will then perform submaximal ramped contractions on the isometric 
leg extension. Each test will be graphically displayed the amount of force you are producing 
when compared to the force production that. After this test you are done with testing for the day. 
 
Leg extension power test – Based upon your performance on the leg extension maximal force 
test you will then perform sets of 3 repetitions at 20, 30, 40, 50, 60, 70, 80, and 90% of the 
maximal load that you successfully performed a full repetition with. Each rep on each set 
performed will be done at the maximal force production that you can accomplish. You will be 
given 2 minute rest periods between each set. 
 
Leg extension adapted Kansas squat test – After performing each of the power sets the load will 
be set at 70% of your one repetition maximum and you will perform 15 repetitions with a 3 
second rest between each rep. Each rep will be performed maximally. 
 
Muscle Biopsy –You have been informed that one of the purposes of this study is to measure the 
muscle fiber type from the muscle samples that we collect.  By obtaining a small sample of your 
muscle tissue (size of a pea), the different types of proteins in your muscle may be determined 
which will be helpful in the evaluation of health and exercise performance.  All muscle tissue 
samples (biopsies) will be taken from the outer portion of the front of the thigh using a needle 
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biopsy technique by either Philip Gallagher or Andy Fry.  Philip Gallagher, PhD., Assistant 
Professor of HSES, and Andrew Fry, PhD., Professor of HSES, have performed over 400 muscle 
biopsies over the past seven years and have assisted on over 1000 biopsies over the past ten years 
on various populations (athletes, sedentary people, elderly etc.) with no significant complications 
and nothing more than minimal adverse reactions. The procedures are supervised by Jeff Burns, 
M.D., who is a medical doctor in Neurology at the KU Medical Center in Kansas City, Kansas.  
The total size of the muscle biopsy will be approximately the size of a pea. You will be placed on 
an examination table lying down on your back (supine) so that the muscles of the leg are relaxed.  
The skin will be thoroughly cleaned with antiseptic solution (Betadine) using sterile cotton 
swabs after which a surgical cover will be placed around the sampling site. If you are allergic to 
Betadine, an alternative antiseptic solution will be used to clean the skin. A small amount (3ml or 
3cc) of a local aesthetic (2% Lidocaine) will be injected into the tissue under the skin around the 
site to be sampled. During this injection you may feel a slight burning sensation. If you are 
allergic to the local anesthetic, or have had allergic reactions to other anesthetics (i.e.: Novocain) 
then you will be disqualified from the study. Following the injection of the numbing agent into 
your thigh, a minimum of five (5) minutes will be allowed to pass to ensure adequate time for the 
agent to take effect in the area where the incision will be made. A small incision (1 cm) will then 
be made in the skin overlying the muscle and the biopsy needle inserted into the middle of the 
muscle (muscle belly) at a depth of 3 cm (about 1 inch). During the time that the sample is being 
taken (about 5 seconds) you may feel some deep pressure and cramping that will be moderately 
painful. You have been informed that if you have been previously diagnosed as having a 
bleeding disorder, a blood clotting problem, take blood thinning medication or have sensitivity to 
scarring, you will tell the researcher and not participate in the biopsy procedure.  
 
Following the biopsy procedure, firm and constant pressure will be placed on the wound to stop 
any bleeding. The incision site will be closed with a Steri-Strip and covered with a large Band-
Aid and the site compressed using a 10 cm strip of elastic tape for a period of 24-hrs.  You have 
been informed that the procedure will take about 20 min.  
Sterile disposable instruments and sterile gloves will be used for the preparation of the site and 
the reusable biopsy needle will be thoroughly sterilized (via steam and heat autoclave) after each 
biopsy.  Approximately 10-12 mg (size of the exposed lead on a pencil) of skeletal muscle tissue 
will be removed. With the invasive skeletal muscle biopsy technique there is the possibility of a 
blood related infection (HIV, Hepatitis B), but the reusable needles will be cleaned and sterilized 
using an autoclave, a generally accepted method of cleaning surgical instruments.  
 
The following three tests will only be performed if you are eligible: 
 
Squat maximum test – Squatting depth in this study will be defined as the upper portion of the 
thighs parallel to the ground. You will be allowed to perform the squat with your preferred 
technique or style as long as it is a back squat. You will not be allowed to use a weight belt or 
knee wraps, but unsupportive knee sleeves will be allowed. After a 5 minute walking warm up 
you will then be given an empty bar to squat for a set of 5 to 10 repetitions. From this point on 
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based upon a predicted squat maximum that you have supplied us you will perform 5 repetitions 
at 30% or your predicted max, 5 repetitions at 50%, 5 repetitions at 60%, 3 repetitions at 70%, 2 
repetitions at 80%, 1 repetition at 90%, 1 repetition at 95%, and 1 repetition at 100%. You will 
be given a 2 minute rest period between each set minimum up to 3 minutes rest. If you feel 
capable of making another attempt after your predicted maximum has been attained you will be 
allowed to do so with the same rest periods applied. After you have attained your maximum for 
that day you are done with testing. 
 
Day 4 testing 
Kansas basketball squat power test – You will take part in a standardized warm up and then 
perform maximal velocity repetitions at 30, 40, 50, 60, 70, 80, and 90% of your one repetition 
maximum. The first 5 sets you will perform 3 repetitions. The final two sets you will perform 2 
or less repetitions depending on your own voluntary decision for fatigue. You will be given 2 
minutes of rest between each set. 
 
Kansas squat test – 70% of your system mass (body weight plus squat 1 repetition maximum) 
will be loaded on the bar and you will perform 15 maximal velocity repetitions with a 6 second 
rest between each rep. After you have finished this test you are done with testing for the day. 
 
RISKS    
 
As a participant there is the potential to experience some physical stress during and muscle 
soreness following the maximal voluntary contractions and the submaximal step contractions.  In 
addition, you may have skin abrasions due to shaving and cleansing the skin with alcohol prior to 
electrode placement. 
 
Muscle Biopsy - The use of local anesthetics will result in a slight burning sensation, lasting 
approximately 5 seconds. There is a risk of allergic reactions to the local injection (1 in 1 
million). There is a small chance of bleeding from the biopsy site. The principle concern would 
be prolonged bleeding which would produce a bruise in the area. This would extend the muscle 
soreness, but is adequately treated with rest, ice, a compression bandage, and keeping the leg 
elevated as much as possible. Nausea, dizziness, and fainting can occur (1 in 100) during the 
biopsy process. As a result, the subjects will be in a supine position during the biopsy procedure. 
There is a risk of infection (1 in 1000) and irritation associated with the biopsy procedure. The 
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use of aseptic techniques, careful cleaning of the skin and keeping the area dry will minimize the 
risk of infection.  There is a risk of bruising (1 in 100) from the biopsy procedure. This will be 
minimized by placing ice over the site following the procedure and by applying a compression 
bandage on the site for the 24 hours following the biopsy. In some instances (1 in 200), some 
motor nerves may be damaged which may cause local muscle atrophy (decrease in the size of 
muscle fibers, with a small dimple on the skin). There is likely to be a small scar where the 
biopsy is performed. This scar usually dissipates over a period of 6-12 months at which time the 
scaring is very modest. 
 
DXA Scan - You are volunteering to participate in a study in which your body composition will 
be assessed using Dual-Energy X-Ray Absorptiometry, commonly referred to as DXA. This 
research study involves a procedure that uses x-rays.  The evaluation is being done not because 
you are sick and the procedure will help you feel better or because it will help your doctor 
diagnose the problem.  There may be no direct benefit to you.  The information that will be 
gained from the x-ray procedure may, however, provide important research data. 
  
The University of Kansas has adopted the philosophy of safety that all exposures to radiation, 
other hazardous materials, and risks from physical hazards shall be kept  ‘as low as reasonable 
achievable.’  There are certain limitations placed upon this procedure to achieve that aim. 
  
If you have received nuclear medicine imagining studies (radionuclide and radiopaque agents) 
within the past two months you may not participate in the study.   These agents will interfere 
with the DXA whole body scan.  If you have metal devices or implants you may not participate 
in the study.  These devices will make whole body measurements difficult to interpret when the 
devices or implants are located within the scan field.  If you have recently undergone CT 
(Computed Tomography), PET, or fluoroscopic, studies, you cannot participate in this study. 
  
The parts of your body that will receive the most radiation are the skin, although your whole 
body will be exposed to the radiation.  During a measurement, the shutter opens to let the x-ray 
beam of radiation pass through the scanner table and patient. The radiation field at the table top 
is 0.75 inches by 0.12 inches.  You will see the arm of the DXA pass systematically back and 
forth over you.  Lead oxide shielding surrounds the x-ray tube insert inside the tube housing 
assembly and reduces radiation levels around the scanner table. 
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The amount of radiation that you will receive from a DXA whole body scan is twenty time less 
than a chest x-ray, and comparable to a Trans-Pacific flight.  The Radiation Safety Officer at the 
University of Kansas can provide you with more information about radiation exposure if you are 
interested. 
  
The DXA measurements are being made by trained personnel who have received formal GE 
training following installation of the DXA for total body scans.  A physician, M.D., Board 
Certified advisor and medical consultant to the program, will provide medical assistance and 
supervision for those who voluntarily participate in the research program. 
  
The system is equipped with a Class II Laser device.  A Class II rating indicates a low power 
visible laser that is not normally hazardous to eyesight but has the potential to be hazardous if 
viewed directly for an extended period of time.  Because of the potential hazard, DO NOT stare 
directly into the beam while the laser is in operation. 
 
 
FOLLOW UP CARE 
 
Following the procedure you will be provided with a biopsy care sheet, extra bandages and 
contact information for Philip Gallagher, Ph.D, Andrew Fry, Ph.D, and Mike Lane. After 24-hrs 
you must report back to the testing coordinator to check the wound.  At this time the bandage 
will be removed and properly disposed of and a new sterile dressing placed over the wound. You 
will again be asked to report to the test coordinator after 3-days and be contacted via phone one 
week after the biopsy or whenever necessary to ensure normal recovery.  The biopsy procedure 
often results in a small fine scar at the site of the incision, however, all care post-treatment will 
aid in reducing the potential for scarring.  All care will be taken to aid in the healing of the 
wound. The entire biopsy procedure will be performed under sterile conditions. All testing staff 
and associated personnel will be trained in first aid and will be familiar with emergency 
procedures.   
 
There have been no other major complications reported in the scientific literature as a result of 
taking small tissue samples from the skeletal muscle using the percutaneous needle biopsy 
technique described above. This procedure has been performed on numerous subjects by 
qualified personnel in many institutions worldwide with only slight discomfort being reported. 
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During the muscle biopsy it is common to feel a strong cramping sensation in the muscle while 
the biopsy is being performed. However, muscle function is not impaired. In fact, subjects have 
been reported to continue participation in sporting events immediately following a muscle 
biopsy. It is common for subjects to experience mild soreness, moderate pain and bruising near 
the biopsy site, similar to a “Charlie-horse” the day after the procedure. In order to allow the 
incisions to heal properly and minimize the risk of infection, you should not get the biopsy site 
wet for 24-hours and avoid prolonged exposure to water for 4-days. Daily showers are 
acceptable (after the first 24-hours), but baths, swimming, sauna’s etc. should be avoided for 4-
days following the biopsy procedure. 
 
BENEFITS 
 
You will not directly benefit from participating in this study. However, you will gain an 
increased understanding of your skeletal muscle function. Specifically, you will learn about your 
level of muscular strength, muscle fiber type, and body composition. A copy of all personal data 
from the tests will be provided to you and your data will be completely explained to you by a 
member of the investigation team.   
 
PARTICIPANT CONFIDENTIALITY 
 
Your name will not be associated in any publication or presentation with the information 
collected about you or with the research findings from this study. Instead, the researcher(s) will 
use a study number or a pseudonym rather than your name.  Your identifiable information will 
not be shared unless (a) it is required by law or university policy, or (b) you give written 
permission. 
 
Permission granted on this date to use and disclose your information remains in effect 
indefinitely. By signing this form you give permission for the use and disclosure of your 
information for purposes of this study at any time in the future.  
    
REFUSAL TO SIGN CONSENT AND AUTHORIZATION 
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You are not required to sign this Consent and Authorization form and you may refuse to do so 
without affecting your right to any services you are receiving or may receive from the University 
of Kansas or to participate in any programs or events of the University of Kansas. However, if 
you refuse to sign, you cannot participate in this study. 
 
CANCELLING THIS CONSENT AND AUTHORIZATION 
 
You may withdraw your consent to participate in this study at any time. You also have the right 
to cancel your permission to use and disclose further information collected about you, in writing, 
at any time, by sending your written request to: Mike Lane, 1301 Sunnyside Avenue 101DC, 
Robinson Center, Lawrence KS 66045.   
 
If you cancel permission to use your information, the researchers will stop collecting additional 
information about you. However, the research team may use and disclose information that was 
gathered before they received your cancellation, as described above.  
 
QUESTIONS ABOUT PARTICIPATION 
 
Questions about procedures should be directed to the researcher(s) listed at the end of this 
consent form. 
 
PARTICIPANT CERTIFICATION: 
 
I have read this Consent and Authorization form. I have had the opportunity to ask, and I have 
received answers to, any questions I had regarding the study. I understand that if I have any 
additional questions about my rights as a research participant, I may call (785) 864-7429 or (785) 
864-7385, write the Human Subjects Committee Lawrence Campus (HSCL), University of 
Kansas, 2385 Irving Hill Road, Lawrence, Kansas 66045-7568, or email irb@ku.edu.  
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I agree to take part in this study as a research participant. By my signature I affirm that I am at 
least 18 years old and that I have received a copy of this Consent and Authorization form.  
 
 
_______________________________         _____________________ 
           Type/Print Participant's Name   Date 
 
 _________________________________________    
                               Participant's Signature 
 
Researcher Contact Information 
 
Mike Lane    Andrew Fry    
Principle Investigator   Applied Physiology Lab  
Applied Physiology Lab  160 Robinson Hall  
101DC Robinson Hall  University of Kansas   
University of Kansas   Lawrence, KS 66045    
Lawrence, KS 66045   785-864-0784    
785-864-0773 
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Appendix B: Health History Questionnaire 
 
 
Name ________________________________________________ Date______________ 
 
Home Address __________________________________________________________________ 
 
Work Phone _______________________  Home Phone ________________________ 
 
Person to contact in case of emergency __________________________________________ 
 
Emergency Contact Phone ______________________ Birthday 
(mm/dd/yy)____/_____/_____ 
 
Personal Physician ____________________________ Physician’s Phone_______________ 
 
Gender ________ Age ______(yrs) Height ______(ft)______(in)     Weight______(lbs) 
 
Does the above weight indicate:  a gain____   a loss____   no change____   in the past year? 
If a change, how many pounds?___________(lbs) 
 
A. JOINT-MUSCLE STATUS (Check areas where you currently have problems) 
 
PRE-EXERCISE TESTING 
HEALTH & EXERCISE STATUS 
QUESTIONNAIRE 
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 Joint Areas      Muscle Areas 
 (    )  Wrists      (    )  Arms 
 (    )  Elbows      (    )  Shoulders 
 (    )  Shoulders      (    )  Chest 
 (    )  Upper Spine & Neck    (    )  Upper Back & Neck 
 (    )  Lower Spine     (    )  Abdominal Regions 
 (    )  Hips      (    )  Lower Back 
 (    )  Knees      (    )  Buttocks 
 (    )  Ankles      (    )  Thighs 
 (    )  Feet      (    )  Lower Leg 
 (    )  Other_______________________   (    )  Feet 
        (    )  Other_____________________ 
 
B.   HEALTH STATUS (Check if you currently have any of the following conditions) 
 
(    )  High Blood Pressure   (    )  Acute Infection 
(    )  Heart Disease or Dysfunction  (    )  Diabetes or Blood Sugar Level Abnormality 
(    )  Peripheral Circulatory Disorder  (    )  Anemia 
(    )  Lung Disease or Dysfunction  (    )  Hernias 
(    )  Arthritis or Gout    (    )  Thyroid Dysfunction 
(    )  Edema     (    )  Pancreas Dysfunction 
(    )  Epilepsy     (    )  Liver Dysfunction 
(    )  Multiply Sclerosis    (    )  Kidney Dysfunction 
(    )  High Blood Cholesterol or   (    )  Phenylketonuria (PKU)  
         Triglyceride Levels   (    )  Loss of Consciousness    
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(    )  Allergic reactions to rubbing alcohol 
 
* NOTE: If any of these conditions are checked, then a physician’s health clearance will 
required.             
           
 
C.   PHYSICAL EXAMINATION HISTORY 
 Approximate date of your last physical examination______________________________ 
  
 Physical problems noted at that time__________________________________________ 
 
 Has a physician ever made any recommendations relative to limiting your level of 
 physical exertion? _________YES __________NO 
 If YES, what limitations were recommended?___________________________________ 
 ________________________________________________________________________ 
 
D.   FEMALE REPRODUCTIVE HISTORY 
If you are male, skip to Section E. 
 Did you begin menses within the past year?  _________YES _________NO 
 
 Have you had consistent menstrual periods for the last 3 months? 
 YES_________ NO_________ 
 
Date of onset of last menstrual period_________________________________________ 
 
 Have you used a hormonal contraceptive within the last 3 months?  
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YES__________ NO__________ 
 
E.   CURRENT MEDICATION USAGE (List the drug name, the condition being managed, and 
the length of time used) 
 
         MEDICATION          CONDITION            LENGTH OF USAGE 
_____________________ ______________________________ _________________ 
_____________________ ______________________________ _________________ 
_____________________ ______________________________ _________________ 
 
F.   PHYSICAL PERCEPTIONS (Indicate any unusual sensations or perceptions.  Check if you 
have recently experienced any of the following during or soon after physical activity (PA); or 
during sedentary periods (SED)) 
PA SED      PA SED 
(    ) (    )  Chest Pain     (    ) (    )  Nausea 
(    ) (    )  Heart Palpitations    (    ) (    )  Light Headedness 
(    ) (    )  Unusually Rapid Breathing  (    ) (    )  Loss of Consciousness 
(    ) (    )  Overheating    (    ) (    )  Loss of Balance 
(    ) (    )  Muscle Cramping    (    ) (    )  Loss of Coordination 
(    ) (    )  Muscle Pain    (    ) (    )  Extreme Weakness 
(    ) (    )  Joint Pain     (    ) (    )  Numbness 
(    ) (    )  Other________________________ (    ) (    )  Mental Confusion 
 
G. FAMILY HISTORY (Check if any of your blood relatives . . . parents, brothers, sisters, aunts, 
uncles, and/or grandparents . . . have or had any of the following) 
 (    )  Heart Disease 
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 (    )  Heart Attacks or Strokes (prior to age 50) 
 (    )  Elevated Blood Cholesterol or Triglyceride Levels 
 (    )  High Blood Pressure 
 (    )  Diabetes 
 (    )  Sudden Death (other than accidental) 
 
H.   EXERCISE STATUS 
Do you regularly engage in aerobic forms of exercise (i.e., jogging, cycling, walking, etc.)?   YES        
NO 
How long have you engaged in this form of exercise?  ______ years ______ months 
How many hours per week do you spend for this type of exercise?  _______ hours 
Do you regularly lift weights?          YES        NO 
How long have you engaged in this form of exercise?  ______ years ______ months 
How many hours per week do you spend for this type of exercise?  _______ hours 
Do you regularly play recreational sports (i.e., basketball, racquetball, volleyball, etc.)?   YES        
NO 
How long have you engaged in this form of exercise?  ______ years ______ months 
How many hours per week do you spend for this type of exercise?  _______ hours 
 
I.   EXERCISE PERFORMANCE (answer only what is applicable to your training) 
What is your mile time?_____________ 
What is your 5k time?_________________ 
What is your 10k time?____________________ 
What is your half marathon/marathon time?___________________ 
What is your maximum back squat?___________________ 
What is your maximum clean?________________ 
What is your maximum snatch?_______________ 
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Appendix C: Biopsy Care Sheet 
CARE AND CLEANING OF YOUR BIOPSY SITE INCISION 
 
Applied Physiology Laboratory 
University of Kansas 
Department of Health, Sport and Exercise Sciences 
 
Following the percutaneous needle biopsy procedure, the incision is closed using steri-strip 
bandages and covered with a large sterile adhesive and pressure bandage. For the proper care of 
the incision site please use the following steps as a guideline. You will receive a ‘care package’ 
that will include additional steri-strips and large and small Band-Aids. Please return to the 
Applied Physiology Lab if you need assistance replacing or require additional bandages. 
 
If you have any questions at anytime while the incision site is healing, please contact: 
Andrew Fry, Ph.D. at (785) 864-0784 or Phil Gallagher, Ph.D. at (785) 864-0772 or (785) 550-
6300 for further instructions.  
 
1. Keep the pressure bandage on for 24 hrs; and avoid getting the area wet during this 
time. 
2. The following day, report back to the testing coordinator to check the wound.  
At this time the bandage will be removed and properly disposed of and a new sterile 
dressing placed over the wound.  
3. If the steri-strip bandage does come off, immediately apply a new steri-strip taking 
care to position the edges of the incision as close together as possible. Please be 
sure to wash your hand before doing this to reduce the likelihood of infection. 
4. Leave the area covered for at least 24-48 hrs. Keep the large adhesive Band-Aid on 
for 3 days & report back to the test coordinator.  
5. At this time the bandage will be removed and properly disposed of and a new sterile 
dressing placed over the wound.  
6. Leave the regular size Band-Aid on for an additional day. After day 4 you can 
remove the Band-Aid and the steri-strip. If you wish you can then just put a regular 
size Band-Aid over the incision site. 
7. When washing, wash around the incision site taking care not to scrub directly over 
the incision or scab that may have formed. 
8. Once you have washed the surrounding area, scrub a few inches above the incision 
site and allow the soap and water to trickle down over the site. 
9. When drying off after washing, take care to lightly dab over the incision site – DO 
NOT rub over the incision site. 
10. After about 3-4 days you may see a scab begin to form. Please allow the scab to 
heal and fall off without assistance. 
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11. You need to contact to project coordinator via phone one week after the biopsy or 
whenever necessary to ensure normal recovery.   
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The biopsy procedure often results in a small fine scar at the site of the incision, however, all 
care post-treatment will aid in reducing the potential for scarring.  All care will be taken to aid in 
the healing of the wound. The entire biopsy procedure will be performed under sterile conditions. 
All testing staff and associated personnel will be trained in first aid and will be familiar with 
emergency procedures.   
This procedure has been performed on numerous subjects by qualified personnel in many 
institutions worldwide with only slight discomfort being reported. Following the muscle biopsy, 
muscle function is not impaired. In fact, subjects have been reported to continue participation in 
sporting events immediately following a muscle biopsy.  
It is common for subjects to experience mild soreness, moderate pain and bruising near the 
biopsy site, similar to a “Charlie-horse” the day after the procedure. It is beneficial to 
periodically apply an ice back to the site the following day to reduce any swelling or residual 
soreness.  Do not take any pain medication or over the counter pain relievers until after the 
final 72 hour post exercise biopsy. 
In order to allow the incisions to heal properly and minimize the risk of infection, you should 
avoid prolonged exposure to water for 4 days. Daily showers are acceptable, but baths, 
swimming, sauna’s etc. should be avoided for 4 days following the biopsy procedure. 
 
 
